| ENSG00000099869.6 |
PF-4708671 |
Bladder urothelial carcinoma |
0.006110471 |
Resistant |
| ENSG00000117242.7 |
PF-4708671 |
Bladder urothelial carcinoma |
0.011072394 |
Resistant |
| ENSG00000177112.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.028591728 |
Resistant |
| ENSG00000179935.5 |
PF-4708671 |
Bladder urothelial carcinoma |
0.021432239 |
Resistant |
| ENSG00000185168.5 |
PF-4708671 |
Bladder urothelial carcinoma |
0.000864549 |
Resistant |
| ENSG00000188825.9 |
PF-4708671 |
Bladder urothelial carcinoma |
0.030588286 |
Resistant |
| ENSG00000196810.4 |
PF-4708671 |
Bladder urothelial carcinoma |
0.004511452 |
Resistant |
| ENSG00000206176.5 |
PF-4708671 |
Bladder urothelial carcinoma |
0.045248134 |
Resistant |
| ENSG00000223764.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.014419295 |
Resistant |
| ENSG00000224794.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.019965979 |
Resistant |
| ENSG00000225963.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.044071342 |
Resistant |
| ENSG00000226047.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.016850829 |
Resistant |
| ENSG00000226332.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.00984012 |
Resistant |
| ENSG00000227188.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.020229244 |
Resistant |
| ENSG00000228113.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.030282142 |
Resistant |
| ENSG00000228791.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.001585474 |
Resistant |
| ENSG00000229167.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.004824623 |
Resistant |
| ENSG00000229589.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.015760568 |
Resistant |
| ENSG00000230266.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.006576581 |
Resistant |
| ENSG00000230424.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.029079549 |
Resistant |
| ENSG00000231064.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.020815106 |
Resistant |
| ENSG00000233255.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.028632071 |
Resistant |
| ENSG00000233515.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.021079449 |
Resistant |
| ENSG00000235298.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.043142435 |
Resistant |
| ENSG00000235373.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.02694931 |
Resistant |
| ENSG00000236384.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.002723135 |
Resistant |
| ENSG00000236423.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.000790158 |
Resistant |
| ENSG00000236526.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.025871393 |
Resistant |
| ENSG00000236861.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.028982879 |
Resistant |
| ENSG00000238260.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.03989716 |
Resistant |
| ENSG00000239523.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.042482557 |
Resistant |
| ENSG00000239906.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.022908798 |
Resistant |
| ENSG00000247271.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.029796022 |
Resistant |
| ENSG00000248202.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.010476398 |
Resistant |
| ENSG00000249306.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.03224057 |
Resistant |
| ENSG00000250240.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.029566957 |
Resistant |
| ENSG00000251191.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.01490611 |
Resistant |
| ENSG00000251513.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.019220889 |
Resistant |
| ENSG00000253582.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.003846729 |
Resistant |
| ENSG00000253917.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.022587875 |
Resistant |
| ENSG00000253955.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.030737951 |
Resistant |
| ENSG00000254263.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.042313795 |
Resistant |
| ENSG00000254837.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.007514617 |
Resistant |
| ENSG00000255980.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.015840679 |
Resistant |
| ENSG00000256588.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.010475166 |
Resistant |
| ENSG00000256670.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.004008961 |
Resistant |
| ENSG00000257433.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.019522771 |
Resistant |
| ENSG00000257829.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.011082213 |
Resistant |
| ENSG00000258096.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.047652166 |
Resistant |
| ENSG00000258410.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.030416523 |
Resistant |
| ENSG00000258676.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.032668293 |
Resistant |
| ENSG00000258701.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.036991186 |
Resistant |
| ENSG00000259115.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.017959903 |
Resistant |
| ENSG00000259714.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.040809989 |
Resistant |
| ENSG00000260046.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.040794192 |
Resistant |
| ENSG00000260766.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.023413196 |
Resistant |
| ENSG00000261167.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.022515578 |
Resistant |
| ENSG00000261254.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.028647629 |
Resistant |
| ENSG00000261437.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.030432256 |
Resistant |
| ENSG00000261888.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.016531357 |
Resistant |
| ENSG00000263080.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.00912561 |
Resistant |
| ENSG00000263718.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.03262878 |
Resistant |
| ENSG00000266805.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.004902616 |
Resistant |
| ENSG00000266895.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.033428122 |
Resistant |
| ENSG00000267194.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.010852753 |
Resistant |
| ENSG00000267265.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.011221677 |
Resistant |
| ENSG00000267344.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.036575763 |
Resistant |
| ENSG00000267481.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.038559691 |
Resistant |
| ENSG00000269386.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.007029865 |
Resistant |
| ENSG00000269959.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.032403771 |
Resistant |
| ENSG00000271359.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.027813951 |
Resistant |
| ENSG00000272091.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.037129036 |
Resistant |
| ENSG00000272198.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.029367479 |
Resistant |
| ENSG00000272425.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.023026662 |
Resistant |
| ENSG00000272452.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.019724043 |
Resistant |
| ENSG00000272834.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.0093914 |
Resistant |
| ENSG00000272848.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.017609057 |
Resistant |
| ENSG00000273004.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.023712588 |
Resistant |
| ENSG00000273375.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.000700715 |
Resistant |
| ENSG00000160336.10 |
PF-4708671 |
Breast invasive carcinoma |
0.049915257 |
Resistant |
| ENSG00000178977.3 |
PF-4708671 |
Breast invasive carcinoma |
0.029322425 |
Resistant |
| ENSG00000185186.4 |
PF-4708671 |
Breast invasive carcinoma |
0.042260922 |
Resistant |
| ENSG00000204625.6 |
PF-4708671 |
Breast invasive carcinoma |
0.044195764 |
Resistant |
| ENSG00000204758.3 |
PF-4708671 |
Breast invasive carcinoma |
0.032525154 |
Resistant |
| ENSG00000223804.1 |
PF-4708671 |
Breast invasive carcinoma |
0.019197473 |
Resistant |
| ENSG00000226009.1 |
PF-4708671 |
Breast invasive carcinoma |
0.045063803 |
Resistant |
| ENSG00000226637.1 |
PF-4708671 |
Breast invasive carcinoma |
0.022128673 |
Resistant |
| ENSG00000227388.2 |
PF-4708671 |
Breast invasive carcinoma |
0.018699089 |
Resistant |
| ENSG00000229647.1 |
PF-4708671 |
Breast invasive carcinoma |
0.037507657 |
Resistant |
| ENSG00000229950.1 |
PF-4708671 |
Breast invasive carcinoma |
0.023533637 |
Resistant |
| ENSG00000230424.1 |
PF-4708671 |
Breast invasive carcinoma |
0.026356345 |
Resistant |
| ENSG00000231346.1 |
PF-4708671 |
Breast invasive carcinoma |
0.031885962 |
Resistant |
| ENSG00000231551.2 |
PF-4708671 |
Breast invasive carcinoma |
0.042953106 |
Resistant |
| ENSG00000231734.4 |
PF-4708671 |
Breast invasive carcinoma |
0.02441797 |
Resistant |
| ENSG00000233244.2 |
PF-4708671 |
Breast invasive carcinoma |
0.037859221 |
Resistant |
| ENSG00000233368.2 |
PF-4708671 |
Breast invasive carcinoma |
0.010404006 |
Resistant |
| ENSG00000235100.3 |
PF-4708671 |
Breast invasive carcinoma |
0.030701853 |
Resistant |
| ENSG00000235501.1 |
PF-4708671 |
Breast invasive carcinoma |
0.009030595 |
Resistant |
| ENSG00000237253.1 |
PF-4708671 |
Breast invasive carcinoma |
0.046703808 |
Resistant |
| ENSG00000237899.1 |
PF-4708671 |
Breast invasive carcinoma |
0.031722698 |
Resistant |
| ENSG00000238186.1 |
PF-4708671 |
Breast invasive carcinoma |
0.004717929 |
Resistant |
| ENSG00000242147.1 |
PF-4708671 |
Breast invasive carcinoma |
0.044387026 |
Resistant |
| ENSG00000242516.1 |
PF-4708671 |
Breast invasive carcinoma |
0.031423657 |
Resistant |
| ENSG00000248161.1 |
PF-4708671 |
Breast invasive carcinoma |
0.03568766 |
Resistant |
| ENSG00000249207.1 |
PF-4708671 |
Breast invasive carcinoma |
0.011203905 |
Resistant |
| ENSG00000250551.1 |
PF-4708671 |
Breast invasive carcinoma |
0.043390659 |
Resistant |
| ENSG00000251292.1 |
PF-4708671 |
Breast invasive carcinoma |
0.039140321 |
Resistant |
| ENSG00000253399.1 |
PF-4708671 |
Breast invasive carcinoma |
0.038530347 |
Resistant |
| ENSG00000254295.1 |
PF-4708671 |
Breast invasive carcinoma |
0.010103756 |
Resistant |
| ENSG00000255867.1 |
PF-4708671 |
Breast invasive carcinoma |
0.040979501 |
Resistant |
| ENSG00000258279.2 |
PF-4708671 |
Breast invasive carcinoma |
0.036777167 |
Resistant |
| ENSG00000258471.1 |
PF-4708671 |
Breast invasive carcinoma |
0.017544651 |
Resistant |
| ENSG00000259583.1 |
PF-4708671 |
Breast invasive carcinoma |
0.014167449 |
Resistant |
| ENSG00000259645.1 |
PF-4708671 |
Breast invasive carcinoma |
0.031264346 |
Resistant |
| ENSG00000260328.1 |
PF-4708671 |
Breast invasive carcinoma |
0.040794968 |
Resistant |
| ENSG00000260953.1 |
PF-4708671 |
Breast invasive carcinoma |
0.0333386 |
Resistant |
| ENSG00000261000.1 |
PF-4708671 |
Breast invasive carcinoma |
0.000753722 |
Resistant |
| ENSG00000261596.1 |
PF-4708671 |
Breast invasive carcinoma |
0.032339128 |
Resistant |
| ENSG00000267421.2 |
PF-4708671 |
Breast invasive carcinoma |
0.039124027 |
Resistant |
| ENSG00000267871.1 |
PF-4708671 |
Breast invasive carcinoma |
0.044430723 |
Resistant |
| ENSG00000269942.1 |
PF-4708671 |
Breast invasive carcinoma |
0.013377971 |
Resistant |
| ENSG00000271715.1 |
PF-4708671 |
Breast invasive carcinoma |
0.029395064 |
Resistant |
| ENSG00000272023.1 |
PF-4708671 |
Breast invasive carcinoma |
0.045744542 |
Resistant |
| ENSG00000272221.1 |
PF-4708671 |
Breast invasive carcinoma |
0.014540603 |
Resistant |
| ENSG00000272695.1 |
PF-4708671 |
Breast invasive carcinoma |
0.048284829 |
Resistant |
| ENSG00000272755.1 |
PF-4708671 |
Breast invasive carcinoma |
0.021548354 |
Resistant |
| ENSG00000272796.1 |
PF-4708671 |
Breast invasive carcinoma |
0.029043635 |
Resistant |
| ENSG00000132204.9 |
PF-4708671 |
Colon adenocarcinoma |
0.007570708 |
Resistant |
| ENSG00000175611.7 |
PF-4708671 |
Colon adenocarcinoma |
0.030015081 |
Resistant |
| ENSG00000177788.5 |
PF-4708671 |
Colon adenocarcinoma |
0.029223836 |
Resistant |
| ENSG00000178440.5 |
PF-4708671 |
Colon adenocarcinoma |
0.028865941 |
Resistant |
| ENSG00000179818.9 |
PF-4708671 |
Colon adenocarcinoma |
0.045620502 |
Resistant |
| ENSG00000185495.6 |
PF-4708671 |
Colon adenocarcinoma |
0.040209741 |
Resistant |
| ENSG00000213742.2 |
PF-4708671 |
Colon adenocarcinoma |
0.032049673 |
Resistant |
| ENSG00000215908.5 |
PF-4708671 |
Colon adenocarcinoma |
0.02033381 |
Resistant |
| ENSG00000218018.2 |
PF-4708671 |
Colon adenocarcinoma |
0.003246438 |
Resistant |
| ENSG00000223374.1 |
PF-4708671 |
Colon adenocarcinoma |
0.002806756 |
Resistant |
| ENSG00000224138.1 |
PF-4708671 |
Colon adenocarcinoma |
0.021677569 |
Resistant |
| ENSG00000224977.1 |
PF-4708671 |
Colon adenocarcinoma |
0.04971419 |
Resistant |
| ENSG00000225783.2 |
PF-4708671 |
Colon adenocarcinoma |
0.001600048 |
Resistant |
| ENSG00000225978.2 |
PF-4708671 |
Colon adenocarcinoma |
0.012323522 |
Resistant |
| ENSG00000226087.1 |
PF-4708671 |
Colon adenocarcinoma |
0.043770354 |
Resistant |
| ENSG00000226419.2 |
PF-4708671 |
Colon adenocarcinoma |
0.020801835 |
Resistant |
| ENSG00000226465.1 |
PF-4708671 |
Colon adenocarcinoma |
0.018372658 |
Resistant |
| ENSG00000227195.4 |
PF-4708671 |
Colon adenocarcinoma |
0.04232304 |
Resistant |
| ENSG00000227627.1 |
PF-4708671 |
Colon adenocarcinoma |
0.007173351 |
Resistant |
| ENSG00000227946.1 |
PF-4708671 |
Colon adenocarcinoma |
0.048770638 |
Resistant |
| ENSG00000228412.2 |
PF-4708671 |
Colon adenocarcinoma |
0.04901068 |
Resistant |
| ENSG00000229122.1 |
PF-4708671 |
Colon adenocarcinoma |
0.047064078 |
Resistant |
| ENSG00000229190.1 |
PF-4708671 |
Colon adenocarcinoma |
0.004915282 |
Resistant |
| ENSG00000229591.1 |
PF-4708671 |
Colon adenocarcinoma |
0.010467651 |
Resistant |
| ENSG00000229692.3 |
PF-4708671 |
Colon adenocarcinoma |
0.018075933 |
Resistant |
| ENSG00000230461.4 |
PF-4708671 |
Colon adenocarcinoma |
0.011646345 |
Resistant |
| ENSG00000231081.1 |
PF-4708671 |
Colon adenocarcinoma |
0.031886793 |
Resistant |
| ENSG00000231119.2 |
PF-4708671 |
Colon adenocarcinoma |
0.000770561 |
Resistant |
| ENSG00000231133.2 |
PF-4708671 |
Colon adenocarcinoma |
0.00000626 |
Resistant |
| ENSG00000231172.2 |
PF-4708671 |
Colon adenocarcinoma |
0.029784656 |
Resistant |
| ENSG00000232645.1 |
PF-4708671 |
Colon adenocarcinoma |
0.010492021 |
Resistant |
| ENSG00000232693.2 |
PF-4708671 |
Colon adenocarcinoma |
0.002208362 |
Resistant |
| ENSG00000233230.1 |
PF-4708671 |
Colon adenocarcinoma |
0.030368342 |
Resistant |
| ENSG00000233799.1 |
PF-4708671 |
Colon adenocarcinoma |
0.00684289 |
Resistant |
| ENSG00000234171.1 |
PF-4708671 |
Colon adenocarcinoma |
0.007450436 |
Resistant |
| ENSG00000234222.2 |
PF-4708671 |
Colon adenocarcinoma |
0.000882742 |
Resistant |
| ENSG00000234252.1 |
PF-4708671 |
Colon adenocarcinoma |
0.031090218 |
Resistant |
| ENSG00000234793.1 |
PF-4708671 |
Colon adenocarcinoma |
0.042050284 |
Resistant |
| ENSG00000235092.1 |
PF-4708671 |
Colon adenocarcinoma |
0.033602443 |
Resistant |
| ENSG00000235448.1 |
PF-4708671 |
Colon adenocarcinoma |
0.004833429 |
Resistant |
| ENSG00000236514.1 |
PF-4708671 |
Colon adenocarcinoma |
0.012185744 |
Resistant |
| ENSG00000237689.1 |
PF-4708671 |
Colon adenocarcinoma |
0.019104187 |
Resistant |
| ENSG00000239353.1 |
PF-4708671 |
Colon adenocarcinoma |
0.013632794 |
Resistant |
| ENSG00000239377.1 |
PF-4708671 |
Colon adenocarcinoma |
0.041693346 |
Resistant |
| ENSG00000239906.1 |
PF-4708671 |
Colon adenocarcinoma |
0.035217374 |
Resistant |
| ENSG00000240571.1 |
PF-4708671 |
Colon adenocarcinoma |
0.017062959 |
Resistant |
| ENSG00000243107.1 |
PF-4708671 |
Colon adenocarcinoma |
0.040659137 |
Resistant |
| ENSG00000245060.2 |
PF-4708671 |
Colon adenocarcinoma |
0.04409962 |
Resistant |
| ENSG00000245694.4 |
PF-4708671 |
Colon adenocarcinoma |
0.037695038 |
Resistant |
| ENSG00000249345.2 |
PF-4708671 |
Colon adenocarcinoma |
0.009636268 |
Resistant |
| ENSG00000249492.1 |
PF-4708671 |
Colon adenocarcinoma |
0.029895321 |
Resistant |
| ENSG00000250057.1 |
PF-4708671 |
Colon adenocarcinoma |
0.026418407 |
Resistant |
| ENSG00000250950.1 |
PF-4708671 |
Colon adenocarcinoma |
0.02894856 |
Resistant |
| ENSG00000251279.1 |
PF-4708671 |
Colon adenocarcinoma |
0.020714348 |
Resistant |
| ENSG00000253343.1 |
PF-4708671 |
Colon adenocarcinoma |
0.0402942 |
Resistant |
| ENSG00000253428.1 |
PF-4708671 |
Colon adenocarcinoma |
0.032892657 |
Resistant |
| ENSG00000253712.1 |
PF-4708671 |
Colon adenocarcinoma |
0.015054637 |
Resistant |
| ENSG00000253754.1 |
PF-4708671 |
Colon adenocarcinoma |
0.023976903 |
Resistant |
| ENSG00000254166.1 |
PF-4708671 |
Colon adenocarcinoma |
0.029365997 |
Resistant |
| ENSG00000254226.1 |
PF-4708671 |
Colon adenocarcinoma |
0.048651764 |
Resistant |
| ENSG00000254369.2 |
PF-4708671 |
Colon adenocarcinoma |
0.032751031 |
Resistant |
| ENSG00000254458.1 |
PF-4708671 |
Colon adenocarcinoma |
0.001549418 |
Resistant |
| ENSG00000254855.1 |
PF-4708671 |
Colon adenocarcinoma |
0.000798141 |
Resistant |
| ENSG00000254990.1 |
PF-4708671 |
Colon adenocarcinoma |
0.031352617 |
Resistant |
| ENSG00000255318.1 |
PF-4708671 |
Colon adenocarcinoma |
0.000242875 |
Resistant |
| ENSG00000255857.1 |
PF-4708671 |
Colon adenocarcinoma |
0.003945037 |
Resistant |
| ENSG00000256001.1 |
PF-4708671 |
Colon adenocarcinoma |
0.010884778 |
Resistant |
| ENSG00000256050.2 |
PF-4708671 |
Colon adenocarcinoma |
0.049265241 |
Resistant |
| ENSG00000256360.1 |
PF-4708671 |
Colon adenocarcinoma |
0.030204564 |
Resistant |
| ENSG00000256452.1 |
PF-4708671 |
Colon adenocarcinoma |
0.040699423 |
Resistant |
| ENSG00000256739.1 |
PF-4708671 |
Colon adenocarcinoma |
0.002217775 |
Resistant |
| ENSG00000257023.1 |
PF-4708671 |
Colon adenocarcinoma |
0.039625148 |
Resistant |
| ENSG00000257621.3 |
PF-4708671 |
Colon adenocarcinoma |
0.041416425 |
Resistant |
| ENSG00000259172.1 |
PF-4708671 |
Colon adenocarcinoma |
0.007712517 |
Resistant |
| ENSG00000259298.1 |
PF-4708671 |
Colon adenocarcinoma |
0.048168379 |
Resistant |
| ENSG00000259456.2 |
PF-4708671 |
Colon adenocarcinoma |
0.019314525 |
Resistant |
| ENSG00000259463.1 |
PF-4708671 |
Colon adenocarcinoma |
0.019352318 |
Resistant |
| ENSG00000259563.1 |
PF-4708671 |
Colon adenocarcinoma |
0.033902426 |
Resistant |
| ENSG00000259783.1 |
PF-4708671 |
Colon adenocarcinoma |
0.002896835 |
Resistant |
| ENSG00000259959.1 |
PF-4708671 |
Colon adenocarcinoma |
0.020178019 |
Resistant |
| ENSG00000259994.1 |
PF-4708671 |
Colon adenocarcinoma |
0.015028836 |
Resistant |
| ENSG00000260051.1 |
PF-4708671 |
Colon adenocarcinoma |
0.043579737 |
Resistant |
| ENSG00000260248.1 |
PF-4708671 |
Colon adenocarcinoma |
0.006698704 |
Resistant |
| ENSG00000260276.1 |
PF-4708671 |
Colon adenocarcinoma |
0.047900059 |
Resistant |
| ENSG00000260396.1 |
PF-4708671 |
Colon adenocarcinoma |
0.011694744 |
Resistant |
| ENSG00000260509.2 |
PF-4708671 |
Colon adenocarcinoma |
0.033104702 |
Resistant |
| ENSG00000260565.2 |
PF-4708671 |
Colon adenocarcinoma |
0.019387842 |
Resistant |
| ENSG00000260572.1 |
PF-4708671 |
Colon adenocarcinoma |
0.028535329 |
Resistant |
| ENSG00000260618.1 |
PF-4708671 |
Colon adenocarcinoma |
0.032620527 |
Resistant |
| ENSG00000260977.1 |
PF-4708671 |
Colon adenocarcinoma |
0.010278054 |
Resistant |
| ENSG00000261337.1 |
PF-4708671 |
Colon adenocarcinoma |
0.031197108 |
Resistant |
| ENSG00000261374.1 |
PF-4708671 |
Colon adenocarcinoma |
0.013282848 |
Resistant |
| ENSG00000261430.1 |
PF-4708671 |
Colon adenocarcinoma |
0.045481889 |
Resistant |
| ENSG00000261474.1 |
PF-4708671 |
Colon adenocarcinoma |
0.030328912 |
Resistant |
| ENSG00000261572.1 |
PF-4708671 |
Colon adenocarcinoma |
0.034480817 |
Resistant |
| ENSG00000261758.1 |
PF-4708671 |
Colon adenocarcinoma |
0.022909386 |
Resistant |
| ENSG00000262380.1 |
PF-4708671 |
Colon adenocarcinoma |
0.038880139 |
Resistant |
| ENSG00000262873.1 |
PF-4708671 |
Colon adenocarcinoma |
0.009767135 |
Resistant |
| ENSG00000263272.1 |
PF-4708671 |
Colon adenocarcinoma |
0.027785144 |
Resistant |
| ENSG00000263683.1 |
PF-4708671 |
Colon adenocarcinoma |
0.006063812 |
Resistant |
| ENSG00000264247.1 |
PF-4708671 |
Colon adenocarcinoma |
0.043659371 |
Resistant |
| ENSG00000265091.1 |
PF-4708671 |
Colon adenocarcinoma |
0.046997631 |
Resistant |
| ENSG00000265334.1 |
PF-4708671 |
Colon adenocarcinoma |
0.000588127 |
Resistant |
| ENSG00000265749.1 |
PF-4708671 |
Colon adenocarcinoma |
0.011315182 |
Resistant |
| ENSG00000265799.1 |
PF-4708671 |
Colon adenocarcinoma |
0.00716018 |
Resistant |
| ENSG00000267117.1 |
PF-4708671 |
Colon adenocarcinoma |
0.028279015 |
Resistant |
| ENSG00000267193.1 |
PF-4708671 |
Colon adenocarcinoma |
0.018066448 |
Resistant |
| ENSG00000267272.1 |
PF-4708671 |
Colon adenocarcinoma |
0.039969949 |
Resistant |
| ENSG00000267898.1 |
PF-4708671 |
Colon adenocarcinoma |
0.012562279 |
Resistant |
| ENSG00000268836.1 |
PF-4708671 |
Colon adenocarcinoma |
0.041268173 |
Resistant |
| ENSG00000269321.1 |
PF-4708671 |
Colon adenocarcinoma |
0.025884195 |
Resistant |
| ENSG00000269973.1 |
PF-4708671 |
Colon adenocarcinoma |
0.047144682 |
Resistant |
| ENSG00000270100.1 |
PF-4708671 |
Colon adenocarcinoma |
0.014153161 |
Resistant |
| ENSG00000270589.1 |
PF-4708671 |
Colon adenocarcinoma |
0.013361984 |
Resistant |
| ENSG00000271228.1 |
PF-4708671 |
Colon adenocarcinoma |
0.00684257 |
Resistant |
| ENSG00000271314.1 |
PF-4708671 |
Colon adenocarcinoma |
0.01377935 |
Resistant |
| ENSG00000271971.1 |
PF-4708671 |
Colon adenocarcinoma |
0.04264583 |
Resistant |
| ENSG00000271991.1 |
PF-4708671 |
Colon adenocarcinoma |
0.001326464 |
Resistant |
| ENSG00000272087.1 |
PF-4708671 |
Colon adenocarcinoma |
0.03493338 |
Resistant |
| ENSG00000272146.1 |
PF-4708671 |
Colon adenocarcinoma |
0.00968891 |
Resistant |
| ENSG00000272148.1 |
PF-4708671 |
Colon adenocarcinoma |
0.044107749 |
Resistant |
| ENSG00000272233.1 |
PF-4708671 |
Colon adenocarcinoma |
0.040674288 |
Resistant |
| ENSG00000272248.1 |
PF-4708671 |
Colon adenocarcinoma |
0.006678523 |
Resistant |
| ENSG00000272255.1 |
PF-4708671 |
Colon adenocarcinoma |
0.022996903 |
Resistant |
| ENSG00000272308.1 |
PF-4708671 |
Colon adenocarcinoma |
0.041771036 |
Resistant |
| ENSG00000272335.1 |
PF-4708671 |
Colon adenocarcinoma |
0.000669544 |
Resistant |
| ENSG00000272374.1 |
PF-4708671 |
Colon adenocarcinoma |
0.006608776 |
Resistant |
| ENSG00000272472.1 |
PF-4708671 |
Colon adenocarcinoma |
0.027550102 |
Resistant |
| ENSG00000272745.1 |
PF-4708671 |
Colon adenocarcinoma |
0.040478303 |
Resistant |
| ENSG00000272954.1 |
PF-4708671 |
Colon adenocarcinoma |
0.030361496 |
Resistant |
| ENSG00000272983.1 |
PF-4708671 |
Colon adenocarcinoma |
0.036771334 |
Resistant |
| ENSG00000273329.1 |
PF-4708671 |
Colon adenocarcinoma |
0.008814941 |
Resistant |
| ENSG00000273350.1 |
PF-4708671 |
Colon adenocarcinoma |
0.03872653 |
Resistant |
| ENSG00000273451.1 |
PF-4708671 |
Colon adenocarcinoma |
0.000926013 |
Resistant |
| ENSG00000212552.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032596065 |
Resistant |
| ENSG00000224844.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042678284 |
Resistant |
| ENSG00000225751.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033824716 |
Resistant |
| ENSG00000227388.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037853816 |
Resistant |
| ENSG00000227673.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030130506 |
Resistant |
| ENSG00000228386.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042051992 |
Resistant |
| ENSG00000228809.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049725384 |
Resistant |
| ENSG00000230612.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024509022 |
Resistant |
| ENSG00000230925.3 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041022418 |
Resistant |
| ENSG00000232754.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036017889 |
Resistant |
| ENSG00000233461.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031668668 |
Resistant |
| ENSG00000233613.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001674468 |
Resistant |
| ENSG00000234230.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.038220348 |
Resistant |
| ENSG00000234945.3 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029898133 |
Resistant |
| ENSG00000235408.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024549797 |
Resistant |
| ENSG00000235927.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04437232 |
Resistant |
| ENSG00000236559.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035818347 |
Resistant |
| ENSG00000237298.4 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043740548 |
Resistant |
| ENSG00000239653.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003231674 |
Resistant |
| ENSG00000241770.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042014517 |
Resistant |
| ENSG00000241818.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023101637 |
Resistant |
| ENSG00000244468.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048237919 |
Resistant |
| ENSG00000245275.3 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015557072 |
Resistant |
| ENSG00000245571.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041940271 |
Resistant |
| ENSG00000246331.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022829168 |
Resistant |
| ENSG00000246422.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029244337 |
Resistant |
| ENSG00000247572.3 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019474112 |
Resistant |
| ENSG00000248734.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01633388 |
Resistant |
| ENSG00000249655.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026518218 |
Resistant |
| ENSG00000250027.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021292378 |
Resistant |
| ENSG00000250410.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034815607 |
Resistant |
| ENSG00000253476.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01786981 |
Resistant |
| ENSG00000253618.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049301097 |
Resistant |
| ENSG00000253829.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047288329 |
Resistant |
| ENSG00000254691.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048742807 |
Resistant |
| ENSG00000254756.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010702385 |
Resistant |
| ENSG00000255843.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048832523 |
Resistant |
| ENSG00000256381.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012979198 |
Resistant |
| ENSG00000258646.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047422009 |
Resistant |
| ENSG00000259631.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049849049 |
Resistant |
| ENSG00000260257.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011261212 |
Resistant |
| ENSG00000260368.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027773179 |
Resistant |
| ENSG00000260774.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03676736 |
Resistant |
| ENSG00000261723.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024962869 |
Resistant |
| ENSG00000262265.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00862376 |
Resistant |
| ENSG00000263345.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0132262 |
Resistant |
| ENSG00000263683.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023445174 |
Resistant |
| ENSG00000264167.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018742704 |
Resistant |
| ENSG00000264290.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000818641 |
Resistant |
| ENSG00000266289.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047381315 |
Resistant |
| ENSG00000266941.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002559952 |
Resistant |
| ENSG00000267039.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.027110217 |
Resistant |
| ENSG00000267117.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016901122 |
Resistant |
| ENSG00000267219.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026372471 |
Resistant |
| ENSG00000267567.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011350912 |
Resistant |
| ENSG00000268340.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001347877 |
Resistant |
| ENSG00000268564.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012592431 |
Resistant |
| ENSG00000269091.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02623396 |
Resistant |
| ENSG00000269938.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025932197 |
Resistant |
| ENSG00000269942.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049668073 |
Resistant |
| ENSG00000269997.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034376854 |
Resistant |
| ENSG00000270061.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025074614 |
Resistant |
| ENSG00000270346.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023259321 |
Resistant |
| ENSG00000271835.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028390875 |
Resistant |
| ENSG00000271843.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036051234 |
Resistant |
| ENSG00000271964.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043325056 |
Resistant |
| ENSG00000273096.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002476301 |
Resistant |
| ENSG00000185904.7 |
PF-4708671 |
Esophageal cancer |
0.004534353 |
Resistant |
| ENSG00000203327.2 |
PF-4708671 |
Esophageal cancer |
0.039769383 |
Resistant |
| ENSG00000215424.5 |
PF-4708671 |
Esophageal cancer |
0.012817377 |
Resistant |
| ENSG00000215692.2 |
PF-4708671 |
Esophageal cancer |
0.003752337 |
Resistant |
| ENSG00000223382.3 |
PF-4708671 |
Esophageal cancer |
0.00006 |
Resistant |
| ENSG00000223396.2 |
PF-4708671 |
Esophageal cancer |
0.042245745 |
Resistant |
| ENSG00000223791.1 |
PF-4708671 |
Esophageal cancer |
0.019552657 |
Resistant |
| ENSG00000224536.1 |
PF-4708671 |
Esophageal cancer |
0.008113305 |
Resistant |
| ENSG00000224790.1 |
PF-4708671 |
Esophageal cancer |
0.000156131 |
Resistant |
| ENSG00000224969.1 |
PF-4708671 |
Esophageal cancer |
0.000939278 |
Resistant |
| ENSG00000225213.2 |
PF-4708671 |
Esophageal cancer |
0.007709146 |
Resistant |
| ENSG00000225234.1 |
PF-4708671 |
Esophageal cancer |
0.026943033 |
Resistant |
| ENSG00000225548.1 |
PF-4708671 |
Esophageal cancer |
0.040292575 |
Resistant |
| ENSG00000226386.1 |
PF-4708671 |
Esophageal cancer |
0.011611456 |
Resistant |
| ENSG00000226416.1 |
PF-4708671 |
Esophageal cancer |
0.017514648 |
Resistant |
| ENSG00000226913.1 |
PF-4708671 |
Esophageal cancer |
0.000576904 |
Resistant |
| ENSG00000227678.3 |
PF-4708671 |
Esophageal cancer |
0.010745113 |
Resistant |
| ENSG00000227811.2 |
PF-4708671 |
Esophageal cancer |
0.011042812 |
Resistant |
| ENSG00000229589.1 |
PF-4708671 |
Esophageal cancer |
0.035554615 |
Resistant |
| ENSG00000229869.1 |
PF-4708671 |
Esophageal cancer |
0.018385897 |
Resistant |
| ENSG00000230337.1 |
PF-4708671 |
Esophageal cancer |
0.01516167 |
Resistant |
| ENSG00000230513.1 |
PF-4708671 |
Esophageal cancer |
0.022993706 |
Resistant |
| ENSG00000230914.2 |
PF-4708671 |
Esophageal cancer |
0.042268958 |
Resistant |
| ENSG00000231105.1 |
PF-4708671 |
Esophageal cancer |
0.001098038 |
Resistant |
| ENSG00000231272.1 |
PF-4708671 |
Esophageal cancer |
0.003344481 |
Resistant |
| ENSG00000231305.3 |
PF-4708671 |
Esophageal cancer |
0.042168276 |
Resistant |
| ENSG00000231346.1 |
PF-4708671 |
Esophageal cancer |
0.009122722 |
Resistant |
| ENSG00000231355.1 |
PF-4708671 |
Esophageal cancer |
0.011851972 |
Resistant |
| ENSG00000231808.1 |
PF-4708671 |
Esophageal cancer |
0.049947244 |
Resistant |
| ENSG00000232098.2 |
PF-4708671 |
Esophageal cancer |
0.044921651 |
Resistant |
| ENSG00000232485.2 |
PF-4708671 |
Esophageal cancer |
0.005769037 |
Resistant |
| ENSG00000232586.1 |
PF-4708671 |
Esophageal cancer |
0.048225091 |
Resistant |
| ENSG00000232940.1 |
PF-4708671 |
Esophageal cancer |
0.036651506 |
Resistant |
| ENSG00000233203.2 |
PF-4708671 |
Esophageal cancer |
0.003200787 |
Resistant |
| ENSG00000233355.2 |
PF-4708671 |
Esophageal cancer |
0.023471439 |
Resistant |
| ENSG00000233825.1 |
PF-4708671 |
Esophageal cancer |
0.044731823 |
Resistant |
| ENSG00000234006.1 |
PF-4708671 |
Esophageal cancer |
0.011499705 |
Resistant |
| ENSG00000234264.1 |
PF-4708671 |
Esophageal cancer |
0.029106825 |
Resistant |
| ENSG00000234978.1 |
PF-4708671 |
Esophageal cancer |
0.040011748 |
Resistant |
| ENSG00000236358.1 |
PF-4708671 |
Esophageal cancer |
0.038478575 |
Resistant |
| ENSG00000236519.1 |
PF-4708671 |
Esophageal cancer |
0.000227038 |
Resistant |
| ENSG00000237438.2 |
PF-4708671 |
Esophageal cancer |
0.024150342 |
Resistant |
| ENSG00000240057.1 |
PF-4708671 |
Esophageal cancer |
0.01808185 |
Resistant |
| ENSG00000241732.1 |
PF-4708671 |
Esophageal cancer |
0.001845169 |
Resistant |
| ENSG00000242396.1 |
PF-4708671 |
Esophageal cancer |
0.037334521 |
Resistant |
| ENSG00000242759.2 |
PF-4708671 |
Esophageal cancer |
0.022149833 |
Resistant |
| ENSG00000243176.1 |
PF-4708671 |
Esophageal cancer |
0.015806847 |
Resistant |
| ENSG00000243479.3 |
PF-4708671 |
Esophageal cancer |
0.00403501 |
Resistant |
| ENSG00000245112.2 |
PF-4708671 |
Esophageal cancer |
0.032366615 |
Resistant |
| ENSG00000246174.3 |
PF-4708671 |
Esophageal cancer |
0.039756405 |
Resistant |
| ENSG00000247228.2 |
PF-4708671 |
Esophageal cancer |
0.047663693 |
Resistant |
| ENSG00000247498.5 |
PF-4708671 |
Esophageal cancer |
0.049001654 |
Resistant |
| ENSG00000248597.1 |
PF-4708671 |
Esophageal cancer |
0.011750351 |
Resistant |
| ENSG00000249894.1 |
PF-4708671 |
Esophageal cancer |
0.001901821 |
Resistant |
| ENSG00000250041.2 |
PF-4708671 |
Esophageal cancer |
0.004777011 |
Resistant |
| ENSG00000250222.1 |
PF-4708671 |
Esophageal cancer |
0.028819945 |
Resistant |
| ENSG00000250421.1 |
PF-4708671 |
Esophageal cancer |
0.043367772 |
Resistant |
| ENSG00000251600.1 |
PF-4708671 |
Esophageal cancer |
0.048073713 |
Resistant |
| ENSG00000253167.1 |
PF-4708671 |
Esophageal cancer |
0.00128601 |
Resistant |
| ENSG00000253392.2 |
PF-4708671 |
Esophageal cancer |
0.037514805 |
Resistant |
| ENSG00000253878.1 |
PF-4708671 |
Esophageal cancer |
0.026848818 |
Resistant |
| ENSG00000254409.1 |
PF-4708671 |
Esophageal cancer |
0.048443712 |
Resistant |
| ENSG00000255121.2 |
PF-4708671 |
Esophageal cancer |
0.008283283 |
Resistant |
| ENSG00000255234.1 |
PF-4708671 |
Esophageal cancer |
0.029141802 |
Resistant |
| ENSG00000255568.2 |
PF-4708671 |
Esophageal cancer |
0.049622533 |
Resistant |
| ENSG00000256146.1 |
PF-4708671 |
Esophageal cancer |
0.048435812 |
Resistant |
| ENSG00000256417.1 |
PF-4708671 |
Esophageal cancer |
0.046639778 |
Resistant |
| ENSG00000256433.1 |
PF-4708671 |
Esophageal cancer |
0.043466787 |
Resistant |
| ENSG00000257999.1 |
PF-4708671 |
Esophageal cancer |
0.045147948 |
Resistant |
| ENSG00000258001.1 |
PF-4708671 |
Esophageal cancer |
0.018947299 |
Resistant |
| ENSG00000258811.1 |
PF-4708671 |
Esophageal cancer |
0.003377467 |
Resistant |
| ENSG00000258957.1 |
PF-4708671 |
Esophageal cancer |
0.040649857 |
Resistant |
| ENSG00000259065.1 |
PF-4708671 |
Esophageal cancer |
0.034163004 |
Resistant |
| ENSG00000259081.1 |
PF-4708671 |
Esophageal cancer |
0.02488964 |
Resistant |
| ENSG00000259782.2 |
PF-4708671 |
Esophageal cancer |
0.015396108 |
Resistant |
| ENSG00000259877.1 |
PF-4708671 |
Esophageal cancer |
0.009937369 |
Resistant |
| ENSG00000260273.1 |
PF-4708671 |
Esophageal cancer |
0.030458763 |
Resistant |
| ENSG00000260352.1 |
PF-4708671 |
Esophageal cancer |
0.021509191 |
Resistant |
| ENSG00000261005.1 |
PF-4708671 |
Esophageal cancer |
0.015152694 |
Resistant |
| ENSG00000261159.1 |
PF-4708671 |
Esophageal cancer |
0.000457016 |
Resistant |
| ENSG00000261204.1 |
PF-4708671 |
Esophageal cancer |
0.033694094 |
Resistant |
| ENSG00000261442.1 |
PF-4708671 |
Esophageal cancer |
0.008621524 |
Resistant |
| ENSG00000261582.1 |
PF-4708671 |
Esophageal cancer |
0.027214976 |
Resistant |
| ENSG00000261777.1 |
PF-4708671 |
Esophageal cancer |
0.006653659 |
Resistant |
| ENSG00000263011.1 |
PF-4708671 |
Esophageal cancer |
0.017583404 |
Resistant |
| ENSG00000264043.2 |
PF-4708671 |
Esophageal cancer |
0.013330035 |
Resistant |
| ENSG00000265349.1 |
PF-4708671 |
Esophageal cancer |
0.036644538 |
Resistant |
| ENSG00000266040.1 |
PF-4708671 |
Esophageal cancer |
0.044565529 |
Resistant |
| ENSG00000266604.1 |
PF-4708671 |
Esophageal cancer |
0.005870425 |
Resistant |
| ENSG00000266821.1 |
PF-4708671 |
Esophageal cancer |
0.046489684 |
Resistant |
| ENSG00000266926.1 |
PF-4708671 |
Esophageal cancer |
0.020869082 |
Resistant |
| ENSG00000266927.2 |
PF-4708671 |
Esophageal cancer |
0.039448595 |
Resistant |
| ENSG00000267009.2 |
PF-4708671 |
Esophageal cancer |
0.001384781 |
Resistant |
| ENSG00000267067.1 |
PF-4708671 |
Esophageal cancer |
0.017504218 |
Resistant |
| ENSG00000267161.1 |
PF-4708671 |
Esophageal cancer |
0.049083543 |
Resistant |
| ENSG00000267381.1 |
PF-4708671 |
Esophageal cancer |
0.024042263 |
Resistant |
| ENSG00000267750.1 |
PF-4708671 |
Esophageal cancer |
0.035748491 |
Resistant |
| ENSG00000268230.1 |
PF-4708671 |
Esophageal cancer |
0.041503386 |
Resistant |
| ENSG00000268543.1 |
PF-4708671 |
Esophageal cancer |
0.016832278 |
Resistant |
| ENSG00000268584.1 |
PF-4708671 |
Esophageal cancer |
0.012112058 |
Resistant |
| ENSG00000268931.1 |
PF-4708671 |
Esophageal cancer |
0.032673665 |
Resistant |
| ENSG00000269486.1 |
PF-4708671 |
Esophageal cancer |
0.034244417 |
Resistant |
| ENSG00000269896.1 |
PF-4708671 |
Esophageal cancer |
0.003963933 |
Resistant |
| ENSG00000270170.1 |
PF-4708671 |
Esophageal cancer |
0.022675113 |
Resistant |
| ENSG00000270419.1 |
PF-4708671 |
Esophageal cancer |
0.018593385 |
Resistant |
| ENSG00000270933.1 |
PF-4708671 |
Esophageal cancer |
0.041719451 |
Resistant |
| ENSG00000271427.1 |
PF-4708671 |
Esophageal cancer |
0.030608347 |
Resistant |
| ENSG00000271646.1 |
PF-4708671 |
Esophageal cancer |
0.011749126 |
Resistant |
| ENSG00000271727.1 |
PF-4708671 |
Esophageal cancer |
0.034169273 |
Resistant |
| ENSG00000272444.1 |
PF-4708671 |
Esophageal cancer |
0.038836945 |
Resistant |
| ENSG00000272529.1 |
PF-4708671 |
Esophageal cancer |
0.020987124 |
Resistant |
| ENSG00000272692.1 |
PF-4708671 |
Esophageal cancer |
0.042801727 |
Resistant |
| ENSG00000272707.1 |
PF-4708671 |
Esophageal cancer |
0.020453366 |
Resistant |
| ENSG00000272709.1 |
PF-4708671 |
Esophageal cancer |
0.026547945 |
Resistant |
| ENSG00000273027.1 |
PF-4708671 |
Esophageal cancer |
0.00026481 |
Resistant |
| ENSG00000273174.1 |
PF-4708671 |
Esophageal cancer |
0.008310257 |
Resistant |
| ENSG00000273203.1 |
PF-4708671 |
Esophageal cancer |
0.010611633 |
Resistant |
| ENSG00000187904.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.023185937 |
Resistant |
| ENSG00000188660.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.032064121 |
Resistant |
| ENSG00000189223.9 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011742702 |
Resistant |
| ENSG00000213904.4 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.019955943 |
Resistant |
| ENSG00000214049.6 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.025382575 |
Resistant |
| ENSG00000223711.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.048283738 |
Resistant |
| ENSG00000226756.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.006664404 |
Resistant |
| ENSG00000227214.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.007485184 |
Resistant |
| ENSG00000227356.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.009901025 |
Resistant |
| ENSG00000228526.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.038847024 |
Resistant |
| ENSG00000228742.5 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.018424213 |
Resistant |
| ENSG00000231465.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011816447 |
Resistant |
| ENSG00000233029.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.021814509 |
Resistant |
| ENSG00000235831.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.018417902 |
Resistant |
| ENSG00000236700.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.0295208 |
Resistant |
| ENSG00000237188.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.006084106 |
Resistant |
| ENSG00000237807.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.041570063 |
Resistant |
| ENSG00000237989.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.040716142 |
Resistant |
| ENSG00000238164.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01576096 |
Resistant |
| ENSG00000241770.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.039690011 |
Resistant |
| ENSG00000244349.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.037220315 |
Resistant |
| ENSG00000248265.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.031210489 |
Resistant |
| ENSG00000249094.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.046479344 |
Resistant |
| ENSG00000251161.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.008320639 |
Resistant |
| ENSG00000254204.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.036586509 |
Resistant |
| ENSG00000257252.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.037048898 |
Resistant |
| ENSG00000257264.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.027928275 |
Resistant |
| ENSG00000258101.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045275383 |
Resistant |
| ENSG00000258354.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.014800749 |
Resistant |
| ENSG00000259771.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.036399282 |
Resistant |
| ENSG00000260086.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.034174779 |
Resistant |
| ENSG00000260954.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.0351883 |
Resistant |
| ENSG00000267308.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.037490255 |
Resistant |
| ENSG00000267547.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.014510424 |
Resistant |
| ENSG00000267644.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.040750522 |
Resistant |
| ENSG00000267745.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.013940114 |
Resistant |
| ENSG00000268601.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.046224019 |
Resistant |
| ENSG00000269994.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.018015396 |
Resistant |
| ENSG00000270072.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.032449515 |
Resistant |
| ENSG00000273071.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.006199509 |
Resistant |
| ENSG00000273281.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.041767406 |
Resistant |
| ENSG00000167912.5 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.001995349 |
Resistant |
| ENSG00000185904.7 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.023972994 |
Resistant |
| ENSG00000186594.8 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.022002912 |
Resistant |
| ENSG00000188660.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.039049516 |
Resistant |
| ENSG00000203364.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.037105801 |
Resistant |
| ENSG00000223829.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.011077407 |
Resistant |
| ENSG00000223975.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.005128439 |
Resistant |
| ENSG00000224020.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.015452144 |
Resistant |
| ENSG00000224046.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.021182172 |
Resistant |
| ENSG00000225764.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.020122812 |
Resistant |
| ENSG00000226471.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.042526181 |
Resistant |
| ENSG00000226965.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.008839024 |
Resistant |
| ENSG00000227356.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.009142269 |
Resistant |
| ENSG00000227908.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.040553015 |
Resistant |
| ENSG00000228719.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.002569229 |
Resistant |
| ENSG00000228838.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.023028113 |
Resistant |
| ENSG00000229153.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.034231966 |
Resistant |
| ENSG00000229368.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.016598305 |
Resistant |
| ENSG00000229647.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.034382885 |
Resistant |
| ENSG00000230065.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.03418514 |
Resistant |
| ENSG00000230417.6 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.009320748 |
Resistant |
| ENSG00000230424.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.044584886 |
Resistant |
| ENSG00000230479.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.000755437 |
Resistant |
| ENSG00000230825.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.00867177 |
Resistant |
| ENSG00000231363.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.033740773 |
Resistant |
| ENSG00000231563.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.024256134 |
Resistant |
| ENSG00000232388.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.004678603 |
Resistant |
| ENSG00000233818.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.001401755 |
Resistant |
| ENSG00000234380.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.045039855 |
Resistant |
| ENSG00000235269.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.029690017 |
Resistant |
| ENSG00000235609.4 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.047657382 |
Resistant |
| ENSG00000235934.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.036848267 |
Resistant |
| ENSG00000237184.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.018919248 |
Resistant |
| ENSG00000237187.4 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.043238924 |
Resistant |
| ENSG00000237689.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.00965113 |
Resistant |
| ENSG00000237738.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.024967523 |
Resistant |
| ENSG00000237950.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.012435243 |
Resistant |
| ENSG00000240143.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.005759284 |
Resistant |
| ENSG00000242082.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.04097168 |
Resistant |
| ENSG00000242808.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.03352807 |
Resistant |
| ENSG00000246731.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.021006769 |
Resistant |
| ENSG00000248367.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.038786426 |
Resistant |
| ENSG00000249609.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.010602232 |
Resistant |
| ENSG00000249697.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.038453249 |
Resistant |
| ENSG00000250075.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.010566309 |
Resistant |
| ENSG00000250234.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.011666288 |
Resistant |
| ENSG00000250988.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.020283048 |
Resistant |
| ENSG00000251143.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.043665462 |
Resistant |
| ENSG00000251179.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.000955552 |
Resistant |
| ENSG00000251279.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.037852175 |
Resistant |
| ENSG00000251532.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.000202707 |
Resistant |
| ENSG00000253746.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.013855577 |
Resistant |
| ENSG00000254226.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.011456301 |
Resistant |
| ENSG00000255197.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.043823558 |
Resistant |
| ENSG00000255446.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.017775568 |
Resistant |
| ENSG00000257391.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.025404608 |
Resistant |
| ENSG00000257563.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.007751795 |
Resistant |
| ENSG00000257815.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.028088159 |
Resistant |
| ENSG00000259867.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.009431882 |
Resistant |
| ENSG00000260329.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.009283169 |
Resistant |
| ENSG00000260626.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.009700864 |
Resistant |
| ENSG00000260633.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.046277379 |
Resistant |
| ENSG00000260877.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.044551216 |
Resistant |
| ENSG00000260992.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.018470754 |
Resistant |
| ENSG00000261105.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.024651451 |
Resistant |
| ENSG00000261188.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.002979462 |
Resistant |
| ENSG00000261490.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.016126647 |
Resistant |
| ENSG00000262445.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.001152208 |
Resistant |
| ENSG00000262454.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.036779169 |
Resistant |
| ENSG00000262873.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.020118103 |
Resistant |
| ENSG00000262979.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.011363157 |
Resistant |
| ENSG00000263717.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.016158172 |
Resistant |
| ENSG00000265478.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.004810052 |
Resistant |
| ENSG00000265962.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.039300346 |
Resistant |
| ENSG00000266903.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.017282088 |
Resistant |
| ENSG00000267405.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.022878079 |
Resistant |
| ENSG00000267551.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.014132393 |
Resistant |
| ENSG00000269202.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.001113266 |
Resistant |
| ENSG00000271874.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.003058576 |
Resistant |
| ENSG00000272191.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.013721996 |
Resistant |
| ENSG00000272523.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.019918274 |
Resistant |
| ENSG00000272659.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.045999112 |
Resistant |
| ENSG00000272866.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.020227802 |
Resistant |
| ENSG00000273058.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.000680555 |
Resistant |
| ENSG00000273102.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.042922261 |
Resistant |
| ENSG00000273293.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.015146584 |
Resistant |
| ENSG00000213279.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.027897188 |
Resistant |
| ENSG00000225555.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.03094791 |
Resistant |
| ENSG00000251161.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029411793 |
Resistant |
| ENSG00000253167.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.032894826 |
Resistant |
| ENSG00000254211.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.026417093 |
Resistant |
| ENSG00000257527.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.027516259 |
Resistant |
| ENSG00000264272.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.026826516 |
Resistant |
| ENSG00000264577.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.014781925 |
Resistant |
| ENSG00000167912.5 |
PF-4708671 |
Brain lower grade glioma |
0.035745714 |
Resistant |
| ENSG00000223542.1 |
PF-4708671 |
Brain lower grade glioma |
0.031631752 |
Resistant |
| ENSG00000227502.2 |
PF-4708671 |
Brain lower grade glioma |
0.048087503 |
Resistant |
| ENSG00000231881.1 |
PF-4708671 |
Brain lower grade glioma |
0.025197278 |
Resistant |
| ENSG00000232019.1 |
PF-4708671 |
Brain lower grade glioma |
0.038758802 |
Resistant |
| ENSG00000235159.1 |
PF-4708671 |
Brain lower grade glioma |
0.042450236 |
Resistant |
| ENSG00000236717.2 |
PF-4708671 |
Brain lower grade glioma |
0.047197407 |
Resistant |
| ENSG00000240093.1 |
PF-4708671 |
Brain lower grade glioma |
0.032525897 |
Resistant |
| ENSG00000248893.3 |
PF-4708671 |
Brain lower grade glioma |
0.036617011 |
Resistant |
| ENSG00000253591.1 |
PF-4708671 |
Brain lower grade glioma |
0.04947352 |
Resistant |
| ENSG00000256482.1 |
PF-4708671 |
Brain lower grade glioma |
0.03272907 |
Resistant |
| ENSG00000258410.1 |
PF-4708671 |
Brain lower grade glioma |
0.040696194 |
Resistant |
| ENSG00000258730.1 |
PF-4708671 |
Brain lower grade glioma |
0.033901954 |
Resistant |
| ENSG00000258982.1 |
PF-4708671 |
Brain lower grade glioma |
0.043740443 |
Resistant |
| ENSG00000259343.1 |
PF-4708671 |
Brain lower grade glioma |
0.018767584 |
Resistant |
| ENSG00000259843.2 |
PF-4708671 |
Brain lower grade glioma |
0.01601836 |
Resistant |
| ENSG00000259888.1 |
PF-4708671 |
Brain lower grade glioma |
0.036031083 |
Resistant |
| ENSG00000261280.2 |
PF-4708671 |
Brain lower grade glioma |
0.043168973 |
Resistant |
| ENSG00000261654.1 |
PF-4708671 |
Brain lower grade glioma |
0.011972733 |
Resistant |
| ENSG00000261773.1 |
PF-4708671 |
Brain lower grade glioma |
0.036957446 |
Resistant |
| ENSG00000262668.1 |
PF-4708671 |
Brain lower grade glioma |
0.049367957 |
Resistant |
| ENSG00000263011.1 |
PF-4708671 |
Brain lower grade glioma |
0.047300118 |
Resistant |
| ENSG00000272763.1 |
PF-4708671 |
Brain lower grade glioma |
0.044432556 |
Resistant |
| ENSG00000273027.1 |
PF-4708671 |
Brain lower grade glioma |
0.017198371 |
Resistant |
| ENSG00000273287.1 |
PF-4708671 |
Brain lower grade glioma |
0.04935755 |
Resistant |
| ENSG00000273428.1 |
PF-4708671 |
Brain lower grade glioma |
0.044761229 |
Resistant |
| ENSG00000088970.11 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.01716323 |
Resistant |
| ENSG00000177822.3 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.021369563 |
Resistant |
| ENSG00000182366.5 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.013750838 |
Resistant |
| ENSG00000182376.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.006962958 |
Resistant |
| ENSG00000188660.3 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.005923057 |
Resistant |
| ENSG00000205663.5 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.02411867 |
Resistant |
| ENSG00000215863.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.020116079 |
Resistant |
| ENSG00000223380.3 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.028997285 |
Resistant |
| ENSG00000226067.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.047716365 |
Resistant |
| ENSG00000226985.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.041179568 |
Resistant |
| ENSG00000227598.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.042503065 |
Resistant |
| ENSG00000228294.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.027172854 |
Resistant |
| ENSG00000229801.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.002504856 |
Resistant |
| ENSG00000229931.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.040986666 |
Resistant |
| ENSG00000230417.6 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.016914077 |
Resistant |
| ENSG00000231154.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.045261225 |
Resistant |
| ENSG00000231612.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.012840331 |
Resistant |
| ENSG00000232973.7 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.021825565 |
Resistant |
| ENSG00000233672.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.01194461 |
Resistant |
| ENSG00000235172.3 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.005053206 |
Resistant |
| ENSG00000235419.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.004336445 |
Resistant |
| ENSG00000235426.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.049486895 |
Resistant |
| ENSG00000235770.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.005199804 |
Resistant |
| ENSG00000236269.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.042090308 |
Resistant |
| ENSG00000237520.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.04605031 |
Resistant |
| ENSG00000237714.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.020621575 |
Resistant |
| ENSG00000246334.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.033534599 |
Resistant |
| ENSG00000248758.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.019683111 |
Resistant |
| ENSG00000250240.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.026223272 |
Resistant |
| ENSG00000250616.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.046304386 |
Resistant |
| ENSG00000251085.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.013761116 |
Resistant |
| ENSG00000254854.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.015694838 |
Resistant |
| ENSG00000255100.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.013569791 |
Resistant |
| ENSG00000256915.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.019224636 |
Resistant |
| ENSG00000257261.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.049699475 |
Resistant |
| ENSG00000257913.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.035308131 |
Resistant |
| ENSG00000258623.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.009038226 |
Resistant |
| ENSG00000259294.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.018925954 |
Resistant |
| ENSG00000259417.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.018428501 |
Resistant |
| ENSG00000260572.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.040806068 |
Resistant |
| ENSG00000260910.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.031901757 |
Resistant |
| ENSG00000261888.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.045889462 |
Resistant |
| ENSG00000262745.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.043872197 |
Resistant |
| ENSG00000263176.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.032984527 |
Resistant |
| ENSG00000267197.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.048036028 |
Resistant |
| ENSG00000270190.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.034820086 |
Resistant |
| ENSG00000271734.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.036598003 |
Resistant |
| ENSG00000271778.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.047669982 |
Resistant |
| ENSG00000205562.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.023269515 |
Resistant |
| ENSG00000214407.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.032248931 |
Resistant |
| ENSG00000214691.6 |
PF-4708671 |
Lung squamous cell carcinoma |
0.032226502 |
Resistant |
| ENSG00000214773.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.006183823 |
Resistant |
| ENSG00000215533.4 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029269655 |
Resistant |
| ENSG00000223552.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.047420552 |
Resistant |
| ENSG00000223725.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022425804 |
Resistant |
| ENSG00000223815.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.00140792 |
Resistant |
| ENSG00000224844.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.006062497 |
Resistant |
| ENSG00000225064.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.016897905 |
Resistant |
| ENSG00000225195.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.001029628 |
Resistant |
| ENSG00000225269.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.03283847 |
Resistant |
| ENSG00000225457.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041403687 |
Resistant |
| ENSG00000225807.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046889932 |
Resistant |
| ENSG00000225839.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.002676434 |
Resistant |
| ENSG00000225889.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036504253 |
Resistant |
| ENSG00000225986.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.043336975 |
Resistant |
| ENSG00000226380.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036501447 |
Resistant |
| ENSG00000226440.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.014443037 |
Resistant |
| ENSG00000226798.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.039361434 |
Resistant |
| ENSG00000227068.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.005536301 |
Resistant |
| ENSG00000227076.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.024666665 |
Resistant |
| ENSG00000227938.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.008917939 |
Resistant |
| ENSG00000228742.5 |
PF-4708671 |
Lung squamous cell carcinoma |
0.010179976 |
Resistant |
| ENSG00000229647.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.012670748 |
Resistant |
| ENSG00000229918.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045813599 |
Resistant |
| ENSG00000230257.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028554392 |
Resistant |
| ENSG00000230323.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.008324717 |
Resistant |
| ENSG00000230684.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.03825311 |
Resistant |
| ENSG00000230815.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.003665281 |
Resistant |
| ENSG00000230836.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.04218326 |
Resistant |
| ENSG00000230918.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.034663396 |
Resistant |
| ENSG00000231298.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.017715252 |
Resistant |
| ENSG00000231816.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.049712863 |
Resistant |
| ENSG00000232259.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.015082145 |
Resistant |
| ENSG00000232325.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.039533407 |
Resistant |
| ENSG00000232386.5 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038138271 |
Resistant |
| ENSG00000232613.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.017709689 |
Resistant |
| ENSG00000232628.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.034626713 |
Resistant |
| ENSG00000232698.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.03029068 |
Resistant |
| ENSG00000233058.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.017601662 |
Resistant |
| ENSG00000233321.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.024651806 |
Resistant |
| ENSG00000233496.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029453473 |
Resistant |
| ENSG00000233844.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.005521463 |
Resistant |
| ENSG00000234076.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036088853 |
Resistant |
| ENSG00000234181.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.04206656 |
Resistant |
| ENSG00000236194.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.018669534 |
Resistant |
| ENSG00000236915.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028929217 |
Resistant |
| ENSG00000237413.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046374272 |
Resistant |
| ENSG00000237499.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.026522079 |
Resistant |
| ENSG00000237588.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.047467966 |
Resistant |
| ENSG00000237807.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.04584481 |
Resistant |
| ENSG00000240015.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.0055607 |
Resistant |
| ENSG00000241280.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036689852 |
Resistant |
| ENSG00000241732.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.031195644 |
Resistant |
| ENSG00000242611.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.015585196 |
Resistant |
| ENSG00000244968.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028125808 |
Resistant |
| ENSG00000246548.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.037039091 |
Resistant |
| ENSG00000246851.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.040084843 |
Resistant |
| ENSG00000248138.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.018168206 |
Resistant |
| ENSG00000248279.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038392918 |
Resistant |
| ENSG00000248571.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038696606 |
Resistant |
| ENSG00000249061.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.034414944 |
Resistant |
| ENSG00000249102.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.004357663 |
Resistant |
| ENSG00000249207.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.048077409 |
Resistant |
| ENSG00000249500.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022356282 |
Resistant |
| ENSG00000249942.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.030237754 |
Resistant |
| ENSG00000250697.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.018624889 |
Resistant |
| ENSG00000251281.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.010274399 |
Resistant |
| ENSG00000253161.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038360232 |
Resistant |
| ENSG00000253266.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044259901 |
Resistant |
| ENSG00000253475.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.02849906 |
Resistant |
| ENSG00000253526.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.005652311 |
Resistant |
| ENSG00000253746.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.042308275 |
Resistant |
| ENSG00000254142.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041327655 |
Resistant |
| ENSG00000254315.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.013135886 |
Resistant |
| ENSG00000254699.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.024754855 |
Resistant |
| ENSG00000254833.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.025889739 |
Resistant |
| ENSG00000254985.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.047864948 |
Resistant |
| ENSG00000255248.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.017858598 |
Resistant |
| ENSG00000255650.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.014267012 |
Resistant |
| ENSG00000255672.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.00700558 |
Resistant |
| ENSG00000255856.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.004412838 |
Resistant |
| ENSG00000255928.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.043385777 |
Resistant |
| ENSG00000256083.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046728898 |
Resistant |
| ENSG00000256128.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.032653839 |
Resistant |
| ENSG00000256915.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.008062104 |
Resistant |
| ENSG00000257114.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045040563 |
Resistant |
| ENSG00000257176.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.001868494 |
Resistant |
| ENSG00000258454.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.015923987 |
Resistant |
| ENSG00000258473.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.047526171 |
Resistant |
| ENSG00000258534.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.004948708 |
Resistant |
| ENSG00000258558.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.014792585 |
Resistant |
| ENSG00000258658.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.007101284 |
Resistant |
| ENSG00000258731.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038269534 |
Resistant |
| ENSG00000258813.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.0069571 |
Resistant |
| ENSG00000258914.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.013899764 |
Resistant |
| ENSG00000258946.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022165376 |
Resistant |
| ENSG00000259125.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.003264131 |
Resistant |
| ENSG00000259230.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.025911471 |
Resistant |
| ENSG00000259294.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.037842488 |
Resistant |
| ENSG00000260310.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.039568336 |
Resistant |
| ENSG00000260585.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028054313 |
Resistant |
| ENSG00000260744.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.035660789 |
Resistant |
| ENSG00000260810.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.048338685 |
Resistant |
| ENSG00000261544.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.039878555 |
Resistant |
| ENSG00000261801.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.033468464 |
Resistant |
| ENSG00000262099.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.048266319 |
Resistant |
| ENSG00000262881.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029245011 |
Resistant |
| ENSG00000263477.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046649782 |
Resistant |
| ENSG00000263893.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.011734691 |
Resistant |
| ENSG00000264666.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.023068358 |
Resistant |
| ENSG00000265113.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.034307862 |
Resistant |
| ENSG00000266805.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.027931522 |
Resistant |
| ENSG00000266916.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.042981785 |
Resistant |
| ENSG00000267052.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.005395672 |
Resistant |
| ENSG00000267191.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.048202931 |
Resistant |
| ENSG00000267273.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.011185233 |
Resistant |
| ENSG00000267758.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022404005 |
Resistant |
| ENSG00000267764.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.034329015 |
Resistant |
| ENSG00000267886.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.019378389 |
Resistant |
| ENSG00000268352.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046493511 |
Resistant |
| ENSG00000269037.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041087956 |
Resistant |
| ENSG00000269086.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.027926742 |
Resistant |
| ENSG00000269289.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.000848543 |
Resistant |
| ENSG00000269397.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.001126432 |
Resistant |
| ENSG00000270174.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.042582607 |
Resistant |
| ENSG00000270607.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.016817712 |
Resistant |
| ENSG00000271109.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.049312534 |
Resistant |
| ENSG00000271390.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041088937 |
Resistant |
| ENSG00000271584.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.021842613 |
Resistant |
| ENSG00000271938.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.026703576 |
Resistant |
| ENSG00000272033.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.027639928 |
Resistant |
| ENSG00000272243.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.035509523 |
Resistant |
| ENSG00000272563.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045237862 |
Resistant |
| ENSG00000272566.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029028883 |
Resistant |
| ENSG00000272620.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.031258704 |
Resistant |
| ENSG00000273348.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038110258 |
Resistant |
| ENSG00000273372.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036242816 |
Resistant |
| ENSG00000157306.10 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004277967 |
Resistant |
| ENSG00000177640.11 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041663047 |
Resistant |
| ENSG00000197670.5 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036577763 |
Resistant |
| ENSG00000203321.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013067101 |
Resistant |
| ENSG00000203325.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016177271 |
Resistant |
| ENSG00000203709.5 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017288948 |
Resistant |
| ENSG00000206417.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007559292 |
Resistant |
| ENSG00000213963.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002900502 |
Resistant |
| ENSG00000214837.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035765467 |
Resistant |
| ENSG00000223759.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041350467 |
Resistant |
| ENSG00000224897.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022959927 |
Resistant |
| ENSG00000225361.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030597049 |
Resistant |
| ENSG00000225798.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037035113 |
Resistant |
| ENSG00000226029.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015392778 |
Resistant |
| ENSG00000227372.6 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048480565 |
Resistant |
| ENSG00000227388.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015979023 |
Resistant |
| ENSG00000228302.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014680742 |
Resistant |
| ENSG00000228327.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041612658 |
Resistant |
| ENSG00000228352.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030087345 |
Resistant |
| ENSG00000228395.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006061543 |
Resistant |
| ENSG00000228544.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032269799 |
Resistant |
| ENSG00000228817.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01053392 |
Resistant |
| ENSG00000229152.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046986331 |
Resistant |
| ENSG00000229180.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008353163 |
Resistant |
| ENSG00000229587.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011702969 |
Resistant |
| ENSG00000229989.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03194236 |
Resistant |
| ENSG00000230021.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028564157 |
Resistant |
| ENSG00000230537.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027116875 |
Resistant |
| ENSG00000230658.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045670377 |
Resistant |
| ENSG00000231113.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038093333 |
Resistant |
| ENSG00000231242.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021900275 |
Resistant |
| ENSG00000231393.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019719492 |
Resistant |
| ENSG00000231616.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022426504 |
Resistant |
| ENSG00000231652.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014286214 |
Resistant |
| ENSG00000231731.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03924752 |
Resistant |
| ENSG00000231856.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024459318 |
Resistant |
| ENSG00000232116.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007907087 |
Resistant |
| ENSG00000232677.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043782896 |
Resistant |
| ENSG00000232692.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025069431 |
Resistant |
| ENSG00000232710.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047246486 |
Resistant |
| ENSG00000233137.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008846512 |
Resistant |
| ENSG00000233246.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036678871 |
Resistant |
| ENSG00000233527.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002096938 |
Resistant |
| ENSG00000233602.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032704643 |
Resistant |
| ENSG00000233613.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000628851 |
Resistant |
| ENSG00000233895.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048132723 |
Resistant |
| ENSG00000234630.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002946431 |
Resistant |
| ENSG00000234789.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040347892 |
Resistant |
| ENSG00000234917.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036895799 |
Resistant |
| ENSG00000235106.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047284967 |
Resistant |
| ENSG00000235298.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026374044 |
Resistant |
| ENSG00000235373.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032612855 |
Resistant |
| ENSG00000235703.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034685695 |
Resistant |
| ENSG00000235897.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007559394 |
Resistant |
| ENSG00000235908.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007390632 |
Resistant |
| ENSG00000236266.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02818699 |
Resistant |
| ENSG00000236498.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008929554 |
Resistant |
| ENSG00000237126.4 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032703805 |
Resistant |
| ENSG00000237399.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014580534 |
Resistant |
| ENSG00000238045.5 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028251506 |
Resistant |
| ENSG00000240137.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026960769 |
Resistant |
| ENSG00000241860.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03046795 |
Resistant |
| ENSG00000242288.6 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027289289 |
Resistant |
| ENSG00000242578.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049694388 |
Resistant |
| ENSG00000244879.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012637856 |
Resistant |
| ENSG00000244945.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026290549 |
Resistant |
| ENSG00000247934.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.011055534 |
Resistant |
| ENSG00000247982.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012634742 |
Resistant |
| ENSG00000248476.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031566532 |
Resistant |
| ENSG00000248515.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041467182 |
Resistant |
| ENSG00000248846.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037094991 |
Resistant |
| ENSG00000248936.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024565271 |
Resistant |
| ENSG00000249637.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001698852 |
Resistant |
| ENSG00000249898.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008331983 |
Resistant |
| ENSG00000250012.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025551492 |
Resistant |
| ENSG00000250116.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009284652 |
Resistant |
| ENSG00000250312.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0409225 |
Resistant |
| ENSG00000250900.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048375793 |
Resistant |
| ENSG00000253559.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040650337 |
Resistant |
| ENSG00000254461.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006394695 |
Resistant |
| ENSG00000255031.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016983246 |
Resistant |
| ENSG00000255158.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032341592 |
Resistant |
| ENSG00000255229.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044070357 |
Resistant |
| ENSG00000255847.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037662609 |
Resistant |
| ENSG00000257354.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026190783 |
Resistant |
| ENSG00000257681.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046519805 |
Resistant |
| ENSG00000258441.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030833493 |
Resistant |
| ENSG00000258454.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022554799 |
Resistant |
| ENSG00000258711.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026380961 |
Resistant |
| ENSG00000258725.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022747519 |
Resistant |
| ENSG00000258904.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004374474 |
Resistant |
| ENSG00000259209.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00979023 |
Resistant |
| ENSG00000259212.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021495774 |
Resistant |
| ENSG00000259215.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.004044752 |
Resistant |
| ENSG00000259310.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04752747 |
Resistant |
| ENSG00000259366.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01472908 |
Resistant |
| ENSG00000259488.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027156728 |
Resistant |
| ENSG00000259635.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032309083 |
Resistant |
| ENSG00000259659.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022163995 |
Resistant |
| ENSG00000259668.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024852472 |
Resistant |
| ENSG00000259712.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030292296 |
Resistant |
| ENSG00000259715.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010435353 |
Resistant |
| ENSG00000259877.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01675919 |
Resistant |
| ENSG00000259972.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005444848 |
Resistant |
| ENSG00000260032.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019474574 |
Resistant |
| ENSG00000260038.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017147713 |
Resistant |
| ENSG00000260051.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005524659 |
Resistant |
| ENSG00000260059.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045705668 |
Resistant |
| ENSG00000260252.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016037889 |
Resistant |
| ENSG00000260279.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013076248 |
Resistant |
| ENSG00000260394.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046022691 |
Resistant |
| ENSG00000260588.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040543008 |
Resistant |
| ENSG00000260591.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030810394 |
Resistant |
| ENSG00000260608.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045623091 |
Resistant |
| ENSG00000260645.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022414242 |
Resistant |
| ENSG00000260884.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04998815 |
Resistant |
| ENSG00000260891.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026334085 |
Resistant |
| ENSG00000260927.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00496124 |
Resistant |
| ENSG00000261079.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043766855 |
Resistant |
| ENSG00000261172.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01001689 |
Resistant |
| ENSG00000261267.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.026859622 |
Resistant |
| ENSG00000261337.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024507131 |
Resistant |
| ENSG00000261396.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028204119 |
Resistant |
| ENSG00000261584.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045672787 |
Resistant |
| ENSG00000261592.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001556836 |
Resistant |
| ENSG00000262115.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035687701 |
Resistant |
| ENSG00000262482.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002347911 |
Resistant |
| ENSG00000262686.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007399945 |
Resistant |
| ENSG00000263393.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009581308 |
Resistant |
| ENSG00000264885.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02606157 |
Resistant |
| ENSG00000265490.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028566149 |
Resistant |
| ENSG00000265625.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03777482 |
Resistant |
| ENSG00000266040.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.031084071 |
Resistant |
| ENSG00000266717.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028497068 |
Resistant |
| ENSG00000267010.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044802498 |
Resistant |
| ENSG00000267058.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021793696 |
Resistant |
| ENSG00000267118.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02343551 |
Resistant |
| ENSG00000267244.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027905498 |
Resistant |
| ENSG00000267705.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044555636 |
Resistant |
| ENSG00000268201.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043341889 |
Resistant |
| ENSG00000268366.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.036006429 |
Resistant |
| ENSG00000269902.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021009283 |
Resistant |
| ENSG00000269951.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025268165 |
Resistant |
| ENSG00000269979.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042010512 |
Resistant |
| ENSG00000269997.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016579262 |
Resistant |
| ENSG00000269999.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013612651 |
Resistant |
| ENSG00000270055.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014548449 |
Resistant |
| ENSG00000270060.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016639642 |
Resistant |
| ENSG00000270061.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022476973 |
Resistant |
| ENSG00000270095.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014410649 |
Resistant |
| ENSG00000270108.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046878032 |
Resistant |
| ENSG00000270184.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012135359 |
Resistant |
| ENSG00000270589.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021992703 |
Resistant |
| ENSG00000270964.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038346751 |
Resistant |
| ENSG00000271816.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025053007 |
Resistant |
| ENSG00000272140.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022114431 |
Resistant |
| ENSG00000272181.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020400276 |
Resistant |
| ENSG00000272216.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043941925 |
Resistant |
| ENSG00000272374.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017418696 |
Resistant |
| ENSG00000272438.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034727995 |
Resistant |
| ENSG00000272720.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01891445 |
Resistant |
| ENSG00000272758.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033939053 |
Resistant |
| ENSG00000272800.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015268923 |
Resistant |
| ENSG00000272812.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012418295 |
Resistant |
| ENSG00000273056.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.010438458 |
Resistant |
| ENSG00000273076.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022988521 |
Resistant |
| ENSG00000273183.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025540191 |
Resistant |
| ENSG00000273343.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039940686 |
Resistant |
| ENSG00000215841.3 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.006144611 |
Resistant |
| ENSG00000223477.3 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.007300771 |
Resistant |
| ENSG00000223784.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.001224133 |
Resistant |
| ENSG00000224606.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.007071657 |
Resistant |
| ENSG00000225163.3 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.037766967 |
Resistant |
| ENSG00000226869.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.026479172 |
Resistant |
| ENSG00000227695.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.049202847 |
Resistant |
| ENSG00000229401.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.032789864 |
Resistant |
| ENSG00000230176.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.028985668 |
Resistant |
| ENSG00000235795.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.01209678 |
Resistant |
| ENSG00000235884.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.001374099 |
Resistant |
| ENSG00000248996.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.044670826 |
Resistant |
| ENSG00000254842.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.002737808 |
Resistant |
| ENSG00000259062.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.034725841 |
Resistant |
| ENSG00000259563.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.016748884 |
Resistant |
| ENSG00000260633.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.032505875 |
Resistant |
| ENSG00000260833.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.029150887 |
Resistant |
| ENSG00000260954.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.009756406 |
Resistant |
| ENSG00000261175.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.025069328 |
Resistant |
| ENSG00000261189.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.012501059 |
Resistant |
| ENSG00000261399.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.027897019 |
Resistant |
| ENSG00000269652.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.045551851 |
Resistant |
| ENSG00000270001.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.033146665 |
Resistant |
| ENSG00000270168.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.038392732 |
Resistant |
| ENSG00000272158.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.047749387 |
Resistant |
| ENSG00000118412.8 |
PF-4708671 |
Sarcoma |
0.028035181 |
Resistant |
| ENSG00000185203.7 |
PF-4708671 |
Sarcoma |
0.03495668 |
Resistant |
| ENSG00000188825.9 |
PF-4708671 |
Sarcoma |
0.017451152 |
Resistant |
| ENSG00000203321.2 |
PF-4708671 |
Sarcoma |
0.029882416 |
Resistant |
| ENSG00000204054.7 |
PF-4708671 |
Sarcoma |
0.021560241 |
Resistant |
| ENSG00000204934.6 |
PF-4708671 |
Sarcoma |
0.034123017 |
Resistant |
| ENSG00000206417.4 |
PF-4708671 |
Sarcoma |
0.01714277 |
Resistant |
| ENSG00000214770.2 |
PF-4708671 |
Sarcoma |
0.011925125 |
Resistant |
| ENSG00000223935.1 |
PF-4708671 |
Sarcoma |
0.047503322 |
Resistant |
| ENSG00000224356.3 |
PF-4708671 |
Sarcoma |
0.035442289 |
Resistant |
| ENSG00000224505.2 |
PF-4708671 |
Sarcoma |
0.036686739 |
Resistant |
| ENSG00000225285.1 |
PF-4708671 |
Sarcoma |
0.049590437 |
Resistant |
| ENSG00000226029.1 |
PF-4708671 |
Sarcoma |
0.03635653 |
Resistant |
| ENSG00000226245.1 |
PF-4708671 |
Sarcoma |
0.021146793 |
Resistant |
| ENSG00000227070.1 |
PF-4708671 |
Sarcoma |
0.038418771 |
Resistant |
| ENSG00000229692.3 |
PF-4708671 |
Sarcoma |
0.038762526 |
Resistant |
| ENSG00000230005.2 |
PF-4708671 |
Sarcoma |
0.017191846 |
Resistant |
| ENSG00000230105.1 |
PF-4708671 |
Sarcoma |
0.022900852 |
Resistant |
| ENSG00000232909.1 |
PF-4708671 |
Sarcoma |
0.029237817 |
Resistant |
| ENSG00000232936.1 |
PF-4708671 |
Sarcoma |
0.014866188 |
Resistant |
| ENSG00000234222.2 |
PF-4708671 |
Sarcoma |
0.016278187 |
Resistant |
| ENSG00000234793.1 |
PF-4708671 |
Sarcoma |
0.015789227 |
Resistant |
| ENSG00000235601.1 |
PF-4708671 |
Sarcoma |
0.04994729 |
Resistant |
| ENSG00000237017.1 |
PF-4708671 |
Sarcoma |
0.016408395 |
Resistant |
| ENSG00000237301.1 |
PF-4708671 |
Sarcoma |
0.028911891 |
Resistant |
| ENSG00000237491.4 |
PF-4708671 |
Sarcoma |
0.008487241 |
Resistant |
| ENSG00000239353.1 |
PF-4708671 |
Sarcoma |
0.014414294 |
Resistant |
| ENSG00000241818.1 |
PF-4708671 |
Sarcoma |
0.028783212 |
Resistant |
| ENSG00000244184.1 |
PF-4708671 |
Sarcoma |
0.026670879 |
Resistant |
| ENSG00000245479.2 |
PF-4708671 |
Sarcoma |
0.044553128 |
Resistant |
| ENSG00000247373.2 |
PF-4708671 |
Sarcoma |
0.037709269 |
Resistant |
| ENSG00000247556.2 |
PF-4708671 |
Sarcoma |
0.020203489 |
Resistant |
| ENSG00000247595.2 |
PF-4708671 |
Sarcoma |
0.034413803 |
Resistant |
| ENSG00000248256.1 |
PF-4708671 |
Sarcoma |
0.009226922 |
Resistant |
| ENSG00000249592.1 |
PF-4708671 |
Sarcoma |
0.027808644 |
Resistant |
| ENSG00000250404.1 |
PF-4708671 |
Sarcoma |
0.00925231 |
Resistant |
| ENSG00000250802.2 |
PF-4708671 |
Sarcoma |
0.007519438 |
Resistant |
| ENSG00000253266.1 |
PF-4708671 |
Sarcoma |
0.046339443 |
Resistant |
| ENSG00000253854.1 |
PF-4708671 |
Sarcoma |
0.015632906 |
Resistant |
| ENSG00000255650.1 |
PF-4708671 |
Sarcoma |
0.019417288 |
Resistant |
| ENSG00000255651.2 |
PF-4708671 |
Sarcoma |
0.008696127 |
Resistant |
| ENSG00000256139.2 |
PF-4708671 |
Sarcoma |
0.031000381 |
Resistant |
| ENSG00000256576.1 |
PF-4708671 |
Sarcoma |
0.045981024 |
Resistant |
| ENSG00000257270.1 |
PF-4708671 |
Sarcoma |
0.048046555 |
Resistant |
| ENSG00000258521.1 |
PF-4708671 |
Sarcoma |
0.044237381 |
Resistant |
| ENSG00000258798.1 |
PF-4708671 |
Sarcoma |
0.047947223 |
Resistant |
| ENSG00000259336.1 |
PF-4708671 |
Sarcoma |
0.029617016 |
Resistant |
| ENSG00000259668.1 |
PF-4708671 |
Sarcoma |
0.011526438 |
Resistant |
| ENSG00000259804.1 |
PF-4708671 |
Sarcoma |
0.031842961 |
Resistant |
| ENSG00000260361.1 |
PF-4708671 |
Sarcoma |
0.042414726 |
Resistant |
| ENSG00000260400.1 |
PF-4708671 |
Sarcoma |
0.00832123 |
Resistant |
| ENSG00000260630.2 |
PF-4708671 |
Sarcoma |
0.011687943 |
Resistant |
| ENSG00000260655.1 |
PF-4708671 |
Sarcoma |
0.032719786 |
Resistant |
| ENSG00000260750.1 |
PF-4708671 |
Sarcoma |
0.049344538 |
Resistant |
| ENSG00000260884.1 |
PF-4708671 |
Sarcoma |
0.02558377 |
Resistant |
| ENSG00000261094.2 |
PF-4708671 |
Sarcoma |
0.039567546 |
Resistant |
| ENSG00000261124.1 |
PF-4708671 |
Sarcoma |
0.025265605 |
Resistant |
| ENSG00000261126.3 |
PF-4708671 |
Sarcoma |
0.043902465 |
Resistant |
| ENSG00000261173.1 |
PF-4708671 |
Sarcoma |
0.02077523 |
Resistant |
| ENSG00000261326.2 |
PF-4708671 |
Sarcoma |
0.016334113 |
Resistant |
| ENSG00000261334.1 |
PF-4708671 |
Sarcoma |
0.01700738 |
Resistant |
| ENSG00000261373.1 |
PF-4708671 |
Sarcoma |
0.028270834 |
Resistant |
| ENSG00000262098.1 |
PF-4708671 |
Sarcoma |
0.03013411 |
Resistant |
| ENSG00000262136.1 |
PF-4708671 |
Sarcoma |
0.027378224 |
Resistant |
| ENSG00000262319.1 |
PF-4708671 |
Sarcoma |
0.037259215 |
Resistant |
| ENSG00000262686.1 |
PF-4708671 |
Sarcoma |
0.043702367 |
Resistant |
| ENSG00000262772.1 |
PF-4708671 |
Sarcoma |
0.034916126 |
Resistant |
| ENSG00000263345.1 |
PF-4708671 |
Sarcoma |
0.045419571 |
Resistant |
| ENSG00000263470.1 |
PF-4708671 |
Sarcoma |
0.000703871 |
Resistant |
| ENSG00000263727.1 |
PF-4708671 |
Sarcoma |
0.045648716 |
Resistant |
| ENSG00000263982.1 |
PF-4708671 |
Sarcoma |
0.002786693 |
Resistant |
| ENSG00000264290.1 |
PF-4708671 |
Sarcoma |
0.040927515 |
Resistant |
| ENSG00000264964.1 |
PF-4708671 |
Sarcoma |
0.034222541 |
Resistant |
| ENSG00000265010.1 |
PF-4708671 |
Sarcoma |
0.020334479 |
Resistant |
| ENSG00000265511.1 |
PF-4708671 |
Sarcoma |
0.03045535 |
Resistant |
| ENSG00000265750.1 |
PF-4708671 |
Sarcoma |
0.042330283 |
Resistant |
| ENSG00000265912.1 |
PF-4708671 |
Sarcoma |
0.001382624 |
Resistant |
| ENSG00000266079.2 |
PF-4708671 |
Sarcoma |
0.041607508 |
Resistant |
| ENSG00000266850.1 |
PF-4708671 |
Sarcoma |
0.016510024 |
Resistant |
| ENSG00000266918.1 |
PF-4708671 |
Sarcoma |
0.04576607 |
Resistant |
| ENSG00000267064.1 |
PF-4708671 |
Sarcoma |
0.023042874 |
Resistant |
| ENSG00000267198.1 |
PF-4708671 |
Sarcoma |
0.006072039 |
Resistant |
| ENSG00000267246.1 |
PF-4708671 |
Sarcoma |
0.008761275 |
Resistant |
| ENSG00000267289.1 |
PF-4708671 |
Sarcoma |
0.044524624 |
Resistant |
| ENSG00000267751.1 |
PF-4708671 |
Sarcoma |
0.038562798 |
Resistant |
| ENSG00000268707.1 |
PF-4708671 |
Sarcoma |
0.024521846 |
Resistant |
| ENSG00000269191.1 |
PF-4708671 |
Sarcoma |
0.0158746 |
Resistant |
| ENSG00000269425.1 |
PF-4708671 |
Sarcoma |
0.049761555 |
Resistant |
| ENSG00000269737.1 |
PF-4708671 |
Sarcoma |
0.042374715 |
Resistant |
| ENSG00000269894.1 |
PF-4708671 |
Sarcoma |
0.025844053 |
Resistant |
| ENSG00000270012.1 |
PF-4708671 |
Sarcoma |
0.049226823 |
Resistant |
| ENSG00000270115.1 |
PF-4708671 |
Sarcoma |
0.016311417 |
Resistant |
| ENSG00000270189.1 |
PF-4708671 |
Sarcoma |
0.027618647 |
Resistant |
| ENSG00000270223.1 |
PF-4708671 |
Sarcoma |
0.044387904 |
Resistant |
| ENSG00000270605.1 |
PF-4708671 |
Sarcoma |
0.018024768 |
Resistant |
| ENSG00000271199.1 |
PF-4708671 |
Sarcoma |
0.024484643 |
Resistant |
| ENSG00000271555.1 |
PF-4708671 |
Sarcoma |
0.040393455 |
Resistant |
| ENSG00000271757.1 |
PF-4708671 |
Sarcoma |
0.044596339 |
Resistant |
| ENSG00000271971.1 |
PF-4708671 |
Sarcoma |
0.013776396 |
Resistant |
| ENSG00000272689.1 |
PF-4708671 |
Sarcoma |
0.038966258 |
Resistant |
| ENSG00000272885.1 |
PF-4708671 |
Sarcoma |
0.011495909 |
Resistant |
| ENSG00000273001.1 |
PF-4708671 |
Sarcoma |
0.012635481 |
Resistant |
| ENSG00000273156.1 |
PF-4708671 |
Sarcoma |
0.046067464 |
Resistant |
| ENSG00000273284.1 |
PF-4708671 |
Sarcoma |
0.026686424 |
Resistant |
| ENSG00000118412.8 |
PF-4708671 |
Skin cutaneous melanoma |
0.022200399 |
Resistant |
| ENSG00000186148.7 |
PF-4708671 |
Skin cutaneous melanoma |
0.043764823 |
Resistant |
| ENSG00000198106.7 |
PF-4708671 |
Skin cutaneous melanoma |
0.031787856 |
Resistant |
| ENSG00000224614.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.047344343 |
Resistant |
| ENSG00000226754.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.022456698 |
Resistant |
| ENSG00000229153.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.014370352 |
Resistant |
| ENSG00000229558.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.015636372 |
Resistant |
| ENSG00000231010.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.028706751 |
Resistant |
| ENSG00000231028.4 |
PF-4708671 |
Skin cutaneous melanoma |
0.037986395 |
Resistant |
| ENSG00000231125.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.003202674 |
Resistant |
| ENSG00000232053.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.028497847 |
Resistant |
| ENSG00000233110.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.025346299 |
Resistant |
| ENSG00000233184.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.001958881 |
Resistant |
| ENSG00000233360.4 |
PF-4708671 |
Skin cutaneous melanoma |
0.006100874 |
Resistant |
| ENSG00000234199.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.049244979 |
Resistant |
| ENSG00000235121.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.031459382 |
Resistant |
| ENSG00000235373.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.029646241 |
Resistant |
| ENSG00000235927.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.010579191 |
Resistant |
| ENSG00000236772.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.011886061 |
Resistant |
| ENSG00000237756.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.026890371 |
Resistant |
| ENSG00000237938.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.014844352 |
Resistant |
| ENSG00000238260.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.048905823 |
Resistant |
| ENSG00000243533.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.013373257 |
Resistant |
| ENSG00000245667.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.02950959 |
Resistant |
| ENSG00000246375.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.04763803 |
Resistant |
| ENSG00000246859.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.00716246 |
Resistant |
| ENSG00000249084.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.015729459 |
Resistant |
| ENSG00000251003.3 |
PF-4708671 |
Skin cutaneous melanoma |
0.009605291 |
Resistant |
| ENSG00000251230.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.013335601 |
Resistant |
| ENSG00000253424.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.035496935 |
Resistant |
| ENSG00000253642.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.033665776 |
Resistant |
| ENSG00000253961.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.0499039 |
Resistant |
| ENSG00000254094.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.03739989 |
Resistant |
| ENSG00000254427.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.049653657 |
Resistant |
| ENSG00000254932.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.018619729 |
Resistant |
| ENSG00000254964.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.00264794 |
Resistant |
| ENSG00000255158.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.04780666 |
Resistant |
| ENSG00000256001.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.03649279 |
Resistant |
| ENSG00000256128.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.04707687 |
Resistant |
| ENSG00000256973.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.000919009 |
Resistant |
| ENSG00000257354.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.02753272 |
Resistant |
| ENSG00000257475.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.045697778 |
Resistant |
| ENSG00000257596.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.007182245 |
Resistant |
| ENSG00000257831.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.027499582 |
Resistant |
| ENSG00000258454.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.029080173 |
Resistant |
| ENSG00000258730.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.046561664 |
Resistant |
| ENSG00000259225.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.048294616 |
Resistant |
| ENSG00000259488.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.001278591 |
Resistant |
| ENSG00000259515.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.015925984 |
Resistant |
| ENSG00000259635.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.038549832 |
Resistant |
| ENSG00000259659.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.035785938 |
Resistant |
| ENSG00000260093.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.043095721 |
Resistant |
| ENSG00000260196.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.045515235 |
Resistant |
| ENSG00000260273.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.040431112 |
Resistant |
| ENSG00000260293.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.003654901 |
Resistant |
| ENSG00000260400.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.026793896 |
Resistant |
| ENSG00000261251.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.039652374 |
Resistant |
| ENSG00000261360.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.007457001 |
Resistant |
| ENSG00000261654.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.006368156 |
Resistant |
| ENSG00000262454.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.047579488 |
Resistant |
| ENSG00000263627.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.031322603 |
Resistant |
| ENSG00000265008.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.010628704 |
Resistant |
| ENSG00000266010.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.047637486 |
Resistant |
| ENSG00000266126.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.049349158 |
Resistant |
| ENSG00000267138.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.022487525 |
Resistant |
| ENSG00000267192.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.009707197 |
Resistant |
| ENSG00000268189.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.044958581 |
Resistant |
| ENSG00000268520.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.008640008 |
Resistant |
| ENSG00000269923.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.041026203 |
Resistant |
| ENSG00000269942.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.007988702 |
Resistant |
| ENSG00000270031.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.046926529 |
Resistant |
| ENSG00000270332.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.015030596 |
Resistant |
| ENSG00000270933.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.020004714 |
Resistant |
| ENSG00000271327.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.013462319 |
Resistant |
| ENSG00000271659.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.013722878 |
Resistant |
| ENSG00000271857.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.002539187 |
Resistant |
| ENSG00000271874.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.031982605 |
Resistant |
| ENSG00000271947.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.04677843 |
Resistant |
| ENSG00000271983.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.03653539 |
Resistant |
| ENSG00000272343.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.029313826 |
Resistant |
| ENSG00000272455.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.042974218 |
Resistant |
| ENSG00000272508.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.002704186 |
Resistant |
| ENSG00000272836.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.004364104 |
Resistant |
| ENSG00000272849.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.037380492 |
Resistant |
| ENSG00000273137.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.007850246 |
Resistant |
| ENSG00000273237.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.0161763 |
Resistant |
| ENSG00000273257.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.044576828 |
Resistant |
| ENSG00000273424.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.024067009 |
Resistant |
| ENSG00000177406.4 |
PF-4708671 |
Stomach adenocarcinoma |
0.030841599 |
Resistant |
| ENSG00000225411.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.009576112 |
Resistant |
| ENSG00000225793.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.013959377 |
Resistant |
| ENSG00000227070.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.044787622 |
Resistant |
| ENSG00000227076.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.036155906 |
Resistant |
| ENSG00000228192.3 |
PF-4708671 |
Stomach adenocarcinoma |
0.033947943 |
Resistant |
| ENSG00000229017.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.045088956 |
Resistant |
| ENSG00000230658.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.027895924 |
Resistant |
| ENSG00000234147.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.049232797 |
Resistant |
| ENSG00000235419.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.003781727 |
Resistant |
| ENSG00000236204.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.012792763 |
Resistant |
| ENSG00000238273.3 |
PF-4708671 |
Stomach adenocarcinoma |
0.007335974 |
Resistant |
| ENSG00000240350.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.009605472 |
Resistant |
| ENSG00000240875.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.001773925 |
Resistant |
| ENSG00000250608.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.015879777 |
Resistant |
| ENSG00000251143.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.002028894 |
Resistant |
| ENSG00000253893.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.043306268 |
Resistant |
| ENSG00000256050.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.018363868 |
Resistant |
| ENSG00000257222.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.033454944 |
Resistant |
| ENSG00000258851.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.028615205 |
Resistant |
| ENSG00000259158.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.049915044 |
Resistant |
| ENSG00000260265.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.046428554 |
Resistant |
| ENSG00000260698.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.009016549 |
Resistant |
| ENSG00000261220.2 |
PF-4708671 |
Stomach adenocarcinoma |
0.046467027 |
Resistant |
| ENSG00000261438.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.016371759 |
Resistant |
| ENSG00000261534.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.041601441 |
Resistant |
| ENSG00000261578.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.023520053 |
Resistant |
| ENSG00000261996.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.048804491 |
Resistant |
| ENSG00000263624.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.008196032 |
Resistant |
| ENSG00000264575.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.03754294 |
Resistant |
| ENSG00000264920.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.020702141 |
Resistant |
| ENSG00000265091.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.018333214 |
Resistant |
| ENSG00000268913.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.00529289 |
Resistant |
| ENSG00000269463.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.037269601 |
Resistant |
| ENSG00000272275.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.046040368 |
Resistant |
| ENSG00000272341.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.006907649 |
Resistant |
| ENSG00000272368.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.023403077 |
Resistant |
| ENSG00000272782.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.035021812 |
Resistant |
| ENSG00000272913.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.02848414 |
Resistant |
| ENSG00000170161.6 |
PF-4708671 |
Bladder urothelial carcinoma |
0.008079551 |
Sensitive |
| ENSG00000213963.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.031987738 |
Sensitive |
| ENSG00000215304.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.034392307 |
Sensitive |
| ENSG00000224086.3 |
PF-4708671 |
Bladder urothelial carcinoma |
0.024301995 |
Sensitive |
| ENSG00000229931.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.049025109 |
Sensitive |
| ENSG00000231010.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.019134949 |
Sensitive |
| ENSG00000232533.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.043215735 |
Sensitive |
| ENSG00000234665.4 |
PF-4708671 |
Bladder urothelial carcinoma |
0.022672004 |
Sensitive |
| ENSG00000238184.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.001957902 |
Sensitive |
| ENSG00000246130.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.039483249 |
Sensitive |
| ENSG00000247134.2 |
PF-4708671 |
Bladder urothelial carcinoma |
0.027061645 |
Sensitive |
| ENSG00000258526.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.013263716 |
Sensitive |
| ENSG00000261572.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.005830743 |
Sensitive |
| ENSG00000267248.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.02165631 |
Sensitive |
| ENSG00000269906.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.008822203 |
Sensitive |
| ENSG00000271978.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.049711621 |
Sensitive |
| ENSG00000272403.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.006403705 |
Sensitive |
| ENSG00000273264.1 |
PF-4708671 |
Bladder urothelial carcinoma |
0.023672486 |
Sensitive |
| ENSG00000184068.2 |
PF-4708671 |
Breast invasive carcinoma |
0.048694708 |
Sensitive |
| ENSG00000205037.2 |
PF-4708671 |
Breast invasive carcinoma |
0.003004214 |
Sensitive |
| ENSG00000215023.2 |
PF-4708671 |
Breast invasive carcinoma |
0.043787379 |
Sensitive |
| ENSG00000224533.3 |
PF-4708671 |
Breast invasive carcinoma |
0.043338137 |
Sensitive |
| ENSG00000224885.1 |
PF-4708671 |
Breast invasive carcinoma |
0.03421193 |
Sensitive |
| ENSG00000225555.1 |
PF-4708671 |
Breast invasive carcinoma |
0.048035078 |
Sensitive |
| ENSG00000227014.1 |
PF-4708671 |
Breast invasive carcinoma |
0.022938445 |
Sensitive |
| ENSG00000228917.1 |
PF-4708671 |
Breast invasive carcinoma |
0.038074438 |
Sensitive |
| ENSG00000230091.2 |
PF-4708671 |
Breast invasive carcinoma |
0.024380245 |
Sensitive |
| ENSG00000230345.1 |
PF-4708671 |
Breast invasive carcinoma |
0.022808403 |
Sensitive |
| ENSG00000231107.1 |
PF-4708671 |
Breast invasive carcinoma |
0.006613264 |
Sensitive |
| ENSG00000231709.1 |
PF-4708671 |
Breast invasive carcinoma |
0.020557287 |
Sensitive |
| ENSG00000232377.1 |
PF-4708671 |
Breast invasive carcinoma |
0.011474498 |
Sensitive |
| ENSG00000233718.1 |
PF-4708671 |
Breast invasive carcinoma |
0.00078748 |
Sensitive |
| ENSG00000234650.1 |
PF-4708671 |
Breast invasive carcinoma |
0.033223252 |
Sensitive |
| ENSG00000235138.1 |
PF-4708671 |
Breast invasive carcinoma |
0.032755966 |
Sensitive |
| ENSG00000235477.2 |
PF-4708671 |
Breast invasive carcinoma |
0.006901482 |
Sensitive |
| ENSG00000236519.1 |
PF-4708671 |
Breast invasive carcinoma |
0.017682289 |
Sensitive |
| ENSG00000236601.1 |
PF-4708671 |
Breast invasive carcinoma |
0.028230324 |
Sensitive |
| ENSG00000236901.3 |
PF-4708671 |
Breast invasive carcinoma |
0.015368855 |
Sensitive |
| ENSG00000237689.1 |
PF-4708671 |
Breast invasive carcinoma |
0.025282251 |
Sensitive |
| ENSG00000238197.1 |
PF-4708671 |
Breast invasive carcinoma |
0.048903298 |
Sensitive |
| ENSG00000240541.2 |
PF-4708671 |
Breast invasive carcinoma |
0.030225763 |
Sensitive |
| ENSG00000243368.2 |
PF-4708671 |
Breast invasive carcinoma |
0.009120004 |
Sensitive |
| ENSG00000243849.1 |
PF-4708671 |
Breast invasive carcinoma |
0.034184103 |
Sensitive |
| ENSG00000243885.1 |
PF-4708671 |
Breast invasive carcinoma |
0.0370379 |
Sensitive |
| ENSG00000248445.1 |
PF-4708671 |
Breast invasive carcinoma |
0.011815187 |
Sensitive |
| ENSG00000249028.2 |
PF-4708671 |
Breast invasive carcinoma |
0.011384071 |
Sensitive |
| ENSG00000253878.1 |
PF-4708671 |
Breast invasive carcinoma |
0.007745033 |
Sensitive |
| ENSG00000254604.1 |
PF-4708671 |
Breast invasive carcinoma |
0.022699268 |
Sensitive |
| ENSG00000255571.2 |
PF-4708671 |
Breast invasive carcinoma |
0.01041202 |
Sensitive |
| ENSG00000255933.1 |
PF-4708671 |
Breast invasive carcinoma |
0.026151532 |
Sensitive |
| ENSG00000258303.1 |
PF-4708671 |
Breast invasive carcinoma |
0.006268891 |
Sensitive |
| ENSG00000258940.2 |
PF-4708671 |
Breast invasive carcinoma |
0.032691128 |
Sensitive |
| ENSG00000259083.1 |
PF-4708671 |
Breast invasive carcinoma |
0.038303176 |
Sensitive |
| ENSG00000260630.2 |
PF-4708671 |
Breast invasive carcinoma |
0.016891512 |
Sensitive |
| ENSG00000260777.1 |
PF-4708671 |
Breast invasive carcinoma |
0.027118509 |
Sensitive |
| ENSG00000261334.1 |
PF-4708671 |
Breast invasive carcinoma |
0.041894021 |
Sensitive |
| ENSG00000261369.1 |
PF-4708671 |
Breast invasive carcinoma |
0.034416522 |
Sensitive |
| ENSG00000261437.1 |
PF-4708671 |
Breast invasive carcinoma |
0.032511205 |
Sensitive |
| ENSG00000261488.1 |
PF-4708671 |
Breast invasive carcinoma |
0.009613675 |
Sensitive |
| ENSG00000261610.1 |
PF-4708671 |
Breast invasive carcinoma |
0.007549261 |
Sensitive |
| ENSG00000261693.1 |
PF-4708671 |
Breast invasive carcinoma |
0.006476008 |
Sensitive |
| ENSG00000262094.1 |
PF-4708671 |
Breast invasive carcinoma |
0.034358893 |
Sensitive |
| ENSG00000262468.1 |
PF-4708671 |
Breast invasive carcinoma |
0.014036634 |
Sensitive |
| ENSG00000263400.2 |
PF-4708671 |
Breast invasive carcinoma |
0.043696633 |
Sensitive |
| ENSG00000264546.1 |
PF-4708671 |
Breast invasive carcinoma |
0.014936019 |
Sensitive |
| ENSG00000267394.1 |
PF-4708671 |
Breast invasive carcinoma |
0.007991882 |
Sensitive |
| ENSG00000269887.1 |
PF-4708671 |
Breast invasive carcinoma |
0.009606486 |
Sensitive |
| ENSG00000270039.1 |
PF-4708671 |
Breast invasive carcinoma |
0.013621124 |
Sensitive |
| ENSG00000270124.1 |
PF-4708671 |
Breast invasive carcinoma |
0.048831143 |
Sensitive |
| ENSG00000271119.1 |
PF-4708671 |
Breast invasive carcinoma |
0.042186762 |
Sensitive |
| ENSG00000271757.1 |
PF-4708671 |
Breast invasive carcinoma |
0.039873884 |
Sensitive |
| ENSG00000271761.1 |
PF-4708671 |
Breast invasive carcinoma |
0.023478967 |
Sensitive |
| ENSG00000272024.1 |
PF-4708671 |
Breast invasive carcinoma |
0.029267886 |
Sensitive |
| ENSG00000272048.1 |
PF-4708671 |
Breast invasive carcinoma |
0.020724966 |
Sensitive |
| ENSG00000272102.1 |
PF-4708671 |
Breast invasive carcinoma |
0.015313623 |
Sensitive |
| ENSG00000272301.1 |
PF-4708671 |
Breast invasive carcinoma |
0.024356567 |
Sensitive |
| ENSG00000272312.1 |
PF-4708671 |
Breast invasive carcinoma |
0.021949463 |
Sensitive |
| ENSG00000272417.1 |
PF-4708671 |
Breast invasive carcinoma |
0.039379501 |
Sensitive |
| ENSG00000272667.1 |
PF-4708671 |
Breast invasive carcinoma |
0.049312567 |
Sensitive |
| ENSG00000273271.1 |
PF-4708671 |
Breast invasive carcinoma |
0.008843811 |
Sensitive |
| ENSG00000224100.1 |
PF-4708671 |
Colon adenocarcinoma |
0.021988476 |
Sensitive |
| ENSG00000224218.1 |
PF-4708671 |
Colon adenocarcinoma |
0.043804741 |
Sensitive |
| ENSG00000229647.1 |
PF-4708671 |
Colon adenocarcinoma |
0.010354461 |
Sensitive |
| ENSG00000234026.1 |
PF-4708671 |
Colon adenocarcinoma |
0.017460669 |
Sensitive |
| ENSG00000234290.2 |
PF-4708671 |
Colon adenocarcinoma |
0.021120687 |
Sensitive |
| ENSG00000234509.1 |
PF-4708671 |
Colon adenocarcinoma |
0.022098999 |
Sensitive |
| ENSG00000256894.1 |
PF-4708671 |
Colon adenocarcinoma |
0.016357254 |
Sensitive |
| ENSG00000260787.1 |
PF-4708671 |
Colon adenocarcinoma |
0.040955393 |
Sensitive |
| ENSG00000272446.1 |
PF-4708671 |
Colon adenocarcinoma |
0.002231832 |
Sensitive |
| ENSG00000227165.3 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029997152 |
Sensitive |
| ENSG00000230939.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018949756 |
Sensitive |
| ENSG00000235545.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02130732 |
Sensitive |
| ENSG00000244300.2 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01310275 |
Sensitive |
| ENSG00000254934.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047607978 |
Sensitive |
| ENSG00000260510.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022960422 |
Sensitive |
| ENSG00000262921.1 |
PF-4708671 |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049178457 |
Sensitive |
| ENSG00000205662.2 |
PF-4708671 |
Esophageal cancer |
0.02772626 |
Sensitive |
| ENSG00000225489.2 |
PF-4708671 |
Esophageal cancer |
0.046448749 |
Sensitive |
| ENSG00000227502.2 |
PF-4708671 |
Esophageal cancer |
0.001010275 |
Sensitive |
| ENSG00000235142.3 |
PF-4708671 |
Esophageal cancer |
0.042000156 |
Sensitive |
| ENSG00000238133.2 |
PF-4708671 |
Esophageal cancer |
0.018177837 |
Sensitive |
| ENSG00000249898.3 |
PF-4708671 |
Esophageal cancer |
0.018347123 |
Sensitive |
| ENSG00000250602.1 |
PF-4708671 |
Esophageal cancer |
0.0312629 |
Sensitive |
| ENSG00000251221.1 |
PF-4708671 |
Esophageal cancer |
0.000724422 |
Sensitive |
| ENSG00000254263.1 |
PF-4708671 |
Esophageal cancer |
0.007526041 |
Sensitive |
| ENSG00000257507.1 |
PF-4708671 |
Esophageal cancer |
0.046380021 |
Sensitive |
| ENSG00000258414.1 |
PF-4708671 |
Esophageal cancer |
0.043574019 |
Sensitive |
| ENSG00000261544.1 |
PF-4708671 |
Esophageal cancer |
0.036417158 |
Sensitive |
| ENSG00000261775.1 |
PF-4708671 |
Esophageal cancer |
0.034275429 |
Sensitive |
| ENSG00000262265.1 |
PF-4708671 |
Esophageal cancer |
0.046150321 |
Sensitive |
| ENSG00000272033.1 |
PF-4708671 |
Esophageal cancer |
0.039915743 |
Sensitive |
| ENSG00000272079.1 |
PF-4708671 |
Esophageal cancer |
0.044897242 |
Sensitive |
| ENSG00000272211.1 |
PF-4708671 |
Esophageal cancer |
0.048894131 |
Sensitive |
| ENSG00000031544.10 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.023371562 |
Sensitive |
| ENSG00000171889.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.02543201 |
Sensitive |
| ENSG00000175699.8 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.002825751 |
Sensitive |
| ENSG00000182376.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.023792067 |
Sensitive |
| ENSG00000206113.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011425739 |
Sensitive |
| ENSG00000206567.5 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.03311048 |
Sensitive |
| ENSG00000214970.4 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045379859 |
Sensitive |
| ENSG00000215386.6 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.049385632 |
Sensitive |
| ENSG00000215417.6 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.008097669 |
Sensitive |
| ENSG00000215869.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.009461223 |
Sensitive |
| ENSG00000223442.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.018827978 |
Sensitive |
| ENSG00000223882.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.02257554 |
Sensitive |
| ENSG00000224057.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.003946933 |
Sensitive |
| ENSG00000224078.8 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026228909 |
Sensitive |
| ENSG00000224429.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.038854353 |
Sensitive |
| ENSG00000224541.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.003112099 |
Sensitive |
| ENSG00000224821.5 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.001541825 |
Sensitive |
| ENSG00000224975.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.006261768 |
Sensitive |
| ENSG00000225234.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045858032 |
Sensitive |
| ENSG00000225798.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01378772 |
Sensitive |
| ENSG00000226310.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.034183869 |
Sensitive |
| ENSG00000226332.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026173132 |
Sensitive |
| ENSG00000226904.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.025525971 |
Sensitive |
| ENSG00000227617.4 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.031205272 |
Sensitive |
| ENSG00000228065.6 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.049283936 |
Sensitive |
| ENSG00000228302.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.031733143 |
Sensitive |
| ENSG00000228573.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.025201203 |
Sensitive |
| ENSG00000229325.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.03889613 |
Sensitive |
| ENSG00000229487.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045892291 |
Sensitive |
| ENSG00000229728.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.005412659 |
Sensitive |
| ENSG00000229841.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.032075407 |
Sensitive |
| ENSG00000231050.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.035566613 |
Sensitive |
| ENSG00000231188.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.007517592 |
Sensitive |
| ENSG00000231611.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026012012 |
Sensitive |
| ENSG00000231628.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.047664741 |
Sensitive |
| ENSG00000231842.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.039795672 |
Sensitive |
| ENSG00000232342.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.014434789 |
Sensitive |
| ENSG00000233006.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.007616311 |
Sensitive |
| ENSG00000233080.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.028719096 |
Sensitive |
| ENSG00000233237.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.008566547 |
Sensitive |
| ENSG00000233967.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.021606148 |
Sensitive |
| ENSG00000234084.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.015384609 |
Sensitive |
| ENSG00000235373.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.000504127 |
Sensitive |
| ENSG00000235408.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.020642889 |
Sensitive |
| ENSG00000235652.3 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.024420391 |
Sensitive |
| ENSG00000235958.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.016084999 |
Sensitive |
| ENSG00000236961.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.025077998 |
Sensitive |
| ENSG00000240498.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.037404397 |
Sensitive |
| ENSG00000243960.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.007454637 |
Sensitive |
| ENSG00000245614.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.012043711 |
Sensitive |
| ENSG00000248367.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026773293 |
Sensitive |
| ENSG00000248714.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.044378893 |
Sensitive |
| ENSG00000248734.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.012828415 |
Sensitive |
| ENSG00000249304.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.016958719 |
Sensitive |
| ENSG00000249379.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.034915767 |
Sensitive |
| ENSG00000250027.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.033572823 |
Sensitive |
| ENSG00000250432.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.00420915 |
Sensitive |
| ENSG00000254428.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.035696026 |
Sensitive |
| ENSG00000254461.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.002585606 |
Sensitive |
| ENSG00000254837.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.003423814 |
Sensitive |
| ENSG00000255148.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01724934 |
Sensitive |
| ENSG00000255176.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.009721424 |
Sensitive |
| ENSG00000255474.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.028401726 |
Sensitive |
| ENSG00000256155.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.002644698 |
Sensitive |
| ENSG00000256973.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.021560775 |
Sensitive |
| ENSG00000257027.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.044157548 |
Sensitive |
| ENSG00000257083.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.0029252 |
Sensitive |
| ENSG00000258175.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.034661783 |
Sensitive |
| ENSG00000258428.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.017345945 |
Sensitive |
| ENSG00000258521.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.035505724 |
Sensitive |
| ENSG00000258857.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.039242539 |
Sensitive |
| ENSG00000259071.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011481302 |
Sensitive |
| ENSG00000259595.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.044318646 |
Sensitive |
| ENSG00000259606.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.014728677 |
Sensitive |
| ENSG00000259617.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01950036 |
Sensitive |
| ENSG00000259652.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011473397 |
Sensitive |
| ENSG00000259974.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.005267002 |
Sensitive |
| ENSG00000260475.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.03858295 |
Sensitive |
| ENSG00000260528.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.019694074 |
Sensitive |
| ENSG00000260534.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.014434067 |
Sensitive |
| ENSG00000260583.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.049540694 |
Sensitive |
| ENSG00000260591.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.009362051 |
Sensitive |
| ENSG00000260719.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.017549456 |
Sensitive |
| ENSG00000260804.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.029501545 |
Sensitive |
| ENSG00000261216.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.000184734 |
Sensitive |
| ENSG00000261428.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.018313302 |
Sensitive |
| ENSG00000261775.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.023683727 |
Sensitive |
| ENSG00000262434.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.027319711 |
Sensitive |
| ENSG00000264167.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.049045872 |
Sensitive |
| ENSG00000266466.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.02025695 |
Sensitive |
| ENSG00000266896.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.00996424 |
Sensitive |
| ENSG00000266922.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045971555 |
Sensitive |
| ENSG00000267082.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.038651667 |
Sensitive |
| ENSG00000267096.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.022872195 |
Sensitive |
| ENSG00000267108.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.039791038 |
Sensitive |
| ENSG00000267316.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.041747652 |
Sensitive |
| ENSG00000268087.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.046579213 |
Sensitive |
| ENSG00000269044.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.019382549 |
Sensitive |
| ENSG00000269815.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026372357 |
Sensitive |
| ENSG00000269893.2 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.008381789 |
Sensitive |
| ENSG00000269925.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.039103698 |
Sensitive |
| ENSG00000270006.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.044591654 |
Sensitive |
| ENSG00000270036.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.005608287 |
Sensitive |
| ENSG00000270605.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.016659301 |
Sensitive |
| ENSG00000271553.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.023172777 |
Sensitive |
| ENSG00000271815.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.045534912 |
Sensitive |
| ENSG00000271843.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.029318346 |
Sensitive |
| ENSG00000272130.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.0092061 |
Sensitive |
| ENSG00000272141.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.017617347 |
Sensitive |
| ENSG00000272146.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.011295062 |
Sensitive |
| ENSG00000272263.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.030676739 |
Sensitive |
| ENSG00000272483.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.024368407 |
Sensitive |
| ENSG00000272662.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01915377 |
Sensitive |
| ENSG00000272810.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.002993415 |
Sensitive |
| ENSG00000272871.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.040553114 |
Sensitive |
| ENSG00000272892.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.01732551 |
Sensitive |
| ENSG00000273133.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.019383986 |
Sensitive |
| ENSG00000273248.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.026598284 |
Sensitive |
| ENSG00000273483.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.002132352 |
Sensitive |
| ENSG00000273488.1 |
PF-4708671 |
Head and neck squamous cell carcinoma |
0.02066536 |
Sensitive |
| ENSG00000226380.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.039303714 |
Sensitive |
| ENSG00000227704.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.030626455 |
Sensitive |
| ENSG00000229463.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.022913417 |
Sensitive |
| ENSG00000229697.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.036421718 |
Sensitive |
| ENSG00000230658.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.034757597 |
Sensitive |
| ENSG00000231920.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.028097229 |
Sensitive |
| ENSG00000232300.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.033941554 |
Sensitive |
| ENSG00000232640.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.026665785 |
Sensitive |
| ENSG00000232719.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.049498187 |
Sensitive |
| ENSG00000234006.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.047992404 |
Sensitive |
| ENSG00000235236.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.010948145 |
Sensitive |
| ENSG00000235652.3 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.048350078 |
Sensitive |
| ENSG00000236651.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.040771829 |
Sensitive |
| ENSG00000241472.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.020558141 |
Sensitive |
| ENSG00000242516.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.00341904 |
Sensitive |
| ENSG00000246263.2 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.04470768 |
Sensitive |
| ENSG00000254165.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.045213286 |
Sensitive |
| ENSG00000255158.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.042379177 |
Sensitive |
| ENSG00000255495.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.016347808 |
Sensitive |
| ENSG00000258561.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.025017552 |
Sensitive |
| ENSG00000258884.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.019303335 |
Sensitive |
| ENSG00000259116.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.00961571 |
Sensitive |
| ENSG00000259138.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.041835225 |
Sensitive |
| ENSG00000259469.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.040716701 |
Sensitive |
| ENSG00000260196.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.036114565 |
Sensitive |
| ENSG00000260645.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.011082125 |
Sensitive |
| ENSG00000265791.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.018845281 |
Sensitive |
| ENSG00000266975.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.015195433 |
Sensitive |
| ENSG00000267169.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.049126186 |
Sensitive |
| ENSG00000267249.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.002123585 |
Sensitive |
| ENSG00000267565.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.040122567 |
Sensitive |
| ENSG00000272079.1 |
PF-4708671 |
Kidney renal clear cell carcinoma |
0.006253414 |
Sensitive |
| ENSG00000188206.5 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.035304963 |
Sensitive |
| ENSG00000203739.3 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.032416252 |
Sensitive |
| ENSG00000204581.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.02639174 |
Sensitive |
| ENSG00000205890.3 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.038467482 |
Sensitive |
| ENSG00000206567.5 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.031016345 |
Sensitive |
| ENSG00000224623.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.049739922 |
Sensitive |
| ENSG00000225057.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.002683787 |
Sensitive |
| ENSG00000225794.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.045003608 |
Sensitive |
| ENSG00000225891.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.033899823 |
Sensitive |
| ENSG00000226746.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.038509016 |
Sensitive |
| ENSG00000226913.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.049503477 |
Sensitive |
| ENSG00000228544.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.025078982 |
Sensitive |
| ENSG00000228661.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.031544325 |
Sensitive |
| ENSG00000229308.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.041065966 |
Sensitive |
| ENSG00000229368.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.04947552 |
Sensitive |
| ENSG00000229487.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.010664682 |
Sensitive |
| ENSG00000229618.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.012321231 |
Sensitive |
| ENSG00000230184.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.026765886 |
Sensitive |
| ENSG00000230454.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.020103921 |
Sensitive |
| ENSG00000230534.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.016187138 |
Sensitive |
| ENSG00000231249.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.012599547 |
Sensitive |
| ENSG00000231704.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.015493308 |
Sensitive |
| ENSG00000231881.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.0493814 |
Sensitive |
| ENSG00000232043.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.015255095 |
Sensitive |
| ENSG00000232160.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.035624654 |
Sensitive |
| ENSG00000232352.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029191385 |
Sensitive |
| ENSG00000232564.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.026220139 |
Sensitive |
| ENSG00000232712.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.036573533 |
Sensitive |
| ENSG00000232754.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.023073677 |
Sensitive |
| ENSG00000234264.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.018142279 |
Sensitive |
| ENSG00000234945.3 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.02224216 |
Sensitive |
| ENSG00000235119.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046504728 |
Sensitive |
| ENSG00000235652.3 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.036576111 |
Sensitive |
| ENSG00000235703.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.008111359 |
Sensitive |
| ENSG00000237017.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.005033122 |
Sensitive |
| ENSG00000237054.5 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.038010659 |
Sensitive |
| ENSG00000237181.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.009748528 |
Sensitive |
| ENSG00000237424.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.02749046 |
Sensitive |
| ENSG00000237798.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.002888573 |
Sensitive |
| ENSG00000237998.3 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.037709897 |
Sensitive |
| ENSG00000238358.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.027413468 |
Sensitive |
| ENSG00000240591.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.049739922 |
Sensitive |
| ENSG00000242622.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.042894875 |
Sensitive |
| ENSG00000245928.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.023855178 |
Sensitive |
| ENSG00000246451.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.00469042 |
Sensitive |
| ENSG00000247095.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.041029628 |
Sensitive |
| ENSG00000248416.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.019032111 |
Sensitive |
| ENSG00000249252.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.03956397 |
Sensitive |
| ENSG00000249791.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046757143 |
Sensitive |
| ENSG00000250938.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.048471037 |
Sensitive |
| ENSG00000254034.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029778497 |
Sensitive |
| ENSG00000254689.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.040345839 |
Sensitive |
| ENSG00000254966.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.035836069 |
Sensitive |
| ENSG00000255557.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.042247672 |
Sensitive |
| ENSG00000257298.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.038458168 |
Sensitive |
| ENSG00000257449.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.031943022 |
Sensitive |
| ENSG00000258667.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046528444 |
Sensitive |
| ENSG00000259062.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.038119889 |
Sensitive |
| ENSG00000259589.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.044905475 |
Sensitive |
| ENSG00000259590.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.025470458 |
Sensitive |
| ENSG00000259933.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.024682097 |
Sensitive |
| ENSG00000260488.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.000186665 |
Sensitive |
| ENSG00000260541.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.044527964 |
Sensitive |
| ENSG00000260545.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.041300749 |
Sensitive |
| ENSG00000260796.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.006272873 |
Sensitive |
| ENSG00000260927.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.009755698 |
Sensitive |
| ENSG00000261024.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.040577228 |
Sensitive |
| ENSG00000261114.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.028492427 |
Sensitive |
| ENSG00000261123.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.01876615 |
Sensitive |
| ENSG00000261187.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029595804 |
Sensitive |
| ENSG00000261193.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.040969227 |
Sensitive |
| ENSG00000261270.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.014523564 |
Sensitive |
| ENSG00000261280.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.04493312 |
Sensitive |
| ENSG00000261455.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.043845555 |
Sensitive |
| ENSG00000261716.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029460521 |
Sensitive |
| ENSG00000263220.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046306553 |
Sensitive |
| ENSG00000264448.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.022040222 |
Sensitive |
| ENSG00000265845.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.02875321 |
Sensitive |
| ENSG00000266445.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.02720869 |
Sensitive |
| ENSG00000266456.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.028762501 |
Sensitive |
| ENSG00000266498.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.016140708 |
Sensitive |
| ENSG00000267064.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.034426492 |
Sensitive |
| ENSG00000267304.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046272984 |
Sensitive |
| ENSG00000267546.2 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.035027882 |
Sensitive |
| ENSG00000267582.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.019050924 |
Sensitive |
| ENSG00000268066.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.022714405 |
Sensitive |
| ENSG00000269066.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.032958629 |
Sensitive |
| ENSG00000269489.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.043389963 |
Sensitive |
| ENSG00000269938.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.039505297 |
Sensitive |
| ENSG00000270009.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.001011035 |
Sensitive |
| ENSG00000270031.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.04422341 |
Sensitive |
| ENSG00000270482.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.018655204 |
Sensitive |
| ENSG00000270996.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.046142764 |
Sensitive |
| ENSG00000271732.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.008360494 |
Sensitive |
| ENSG00000271993.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.029313925 |
Sensitive |
| ENSG00000272198.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.044600689 |
Sensitive |
| ENSG00000272255.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.043512954 |
Sensitive |
| ENSG00000272646.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.032705766 |
Sensitive |
| ENSG00000272993.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.027134448 |
Sensitive |
| ENSG00000273081.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.004936091 |
Sensitive |
| ENSG00000273374.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.026506288 |
Sensitive |
| ENSG00000273448.1 |
PF-4708671 |
Chronic Lymphocytic Leukemia |
0.011668664 |
Sensitive |
| ENSG00000197670.5 |
PF-4708671 |
Brain lower grade glioma |
0.010443612 |
Sensitive |
| ENSG00000224490.1 |
PF-4708671 |
Brain lower grade glioma |
0.032345795 |
Sensitive |
| ENSG00000226690.2 |
PF-4708671 |
Brain lower grade glioma |
0.041583041 |
Sensitive |
| ENSG00000226824.2 |
PF-4708671 |
Brain lower grade glioma |
0.03589532 |
Sensitive |
| ENSG00000228412.2 |
PF-4708671 |
Brain lower grade glioma |
0.040019707 |
Sensitive |
| ENSG00000228573.1 |
PF-4708671 |
Brain lower grade glioma |
0.032087069 |
Sensitive |
| ENSG00000234070.1 |
PF-4708671 |
Brain lower grade glioma |
0.047733277 |
Sensitive |
| ENSG00000234509.1 |
PF-4708671 |
Brain lower grade glioma |
0.040851978 |
Sensitive |
| ENSG00000236423.1 |
PF-4708671 |
Brain lower grade glioma |
0.012809932 |
Sensitive |
| ENSG00000236559.1 |
PF-4708671 |
Brain lower grade glioma |
0.016231102 |
Sensitive |
| ENSG00000236896.1 |
PF-4708671 |
Brain lower grade glioma |
0.016456888 |
Sensitive |
| ENSG00000240571.1 |
PF-4708671 |
Brain lower grade glioma |
0.033490982 |
Sensitive |
| ENSG00000242798.1 |
PF-4708671 |
Brain lower grade glioma |
0.016875249 |
Sensitive |
| ENSG00000243055.1 |
PF-4708671 |
Brain lower grade glioma |
0.025674466 |
Sensitive |
| ENSG00000247151.2 |
PF-4708671 |
Brain lower grade glioma |
0.011905448 |
Sensitive |
| ENSG00000248968.1 |
PF-4708671 |
Brain lower grade glioma |
0.018929843 |
Sensitive |
| ENSG00000249664.1 |
PF-4708671 |
Brain lower grade glioma |
0.016659066 |
Sensitive |
| ENSG00000250590.1 |
PF-4708671 |
Brain lower grade glioma |
0.048335223 |
Sensitive |
| ENSG00000250608.1 |
PF-4708671 |
Brain lower grade glioma |
0.047579235 |
Sensitive |
| ENSG00000250938.1 |
PF-4708671 |
Brain lower grade glioma |
0.038189413 |
Sensitive |
| ENSG00000251003.3 |
PF-4708671 |
Brain lower grade glioma |
0.023964943 |
Sensitive |
| ENSG00000254821.1 |
PF-4708671 |
Brain lower grade glioma |
0.025637106 |
Sensitive |
| ENSG00000256250.1 |
PF-4708671 |
Brain lower grade glioma |
0.022111528 |
Sensitive |
| ENSG00000256299.1 |
PF-4708671 |
Brain lower grade glioma |
0.046295045 |
Sensitive |
| ENSG00000258010.2 |
PF-4708671 |
Brain lower grade glioma |
0.046416491 |
Sensitive |
| ENSG00000259125.1 |
PF-4708671 |
Brain lower grade glioma |
0.005210561 |
Sensitive |
| ENSG00000259212.1 |
PF-4708671 |
Brain lower grade glioma |
0.030123352 |
Sensitive |
| ENSG00000259782.2 |
PF-4708671 |
Brain lower grade glioma |
0.013672319 |
Sensitive |
| ENSG00000260932.1 |
PF-4708671 |
Brain lower grade glioma |
0.038165971 |
Sensitive |
| ENSG00000261610.1 |
PF-4708671 |
Brain lower grade glioma |
0.001995542 |
Sensitive |
| ENSG00000261697.1 |
PF-4708671 |
Brain lower grade glioma |
0.019913063 |
Sensitive |
| ENSG00000262777.1 |
PF-4708671 |
Brain lower grade glioma |
0.0086285 |
Sensitive |
| ENSG00000263370.1 |
PF-4708671 |
Brain lower grade glioma |
0.036423323 |
Sensitive |
| ENSG00000264196.1 |
PF-4708671 |
Brain lower grade glioma |
0.031505053 |
Sensitive |
| ENSG00000264235.1 |
PF-4708671 |
Brain lower grade glioma |
0.023506615 |
Sensitive |
| ENSG00000264769.1 |
PF-4708671 |
Brain lower grade glioma |
0.031767113 |
Sensitive |
| ENSG00000265205.1 |
PF-4708671 |
Brain lower grade glioma |
0.040558485 |
Sensitive |
| ENSG00000265394.1 |
PF-4708671 |
Brain lower grade glioma |
0.015844808 |
Sensitive |
| ENSG00000266498.1 |
PF-4708671 |
Brain lower grade glioma |
0.036840542 |
Sensitive |
| ENSG00000267042.1 |
PF-4708671 |
Brain lower grade glioma |
0.034057523 |
Sensitive |
| ENSG00000267199.1 |
PF-4708671 |
Brain lower grade glioma |
0.040836077 |
Sensitive |
| ENSG00000267405.1 |
PF-4708671 |
Brain lower grade glioma |
0.031940397 |
Sensitive |
| ENSG00000273142.1 |
PF-4708671 |
Brain lower grade glioma |
0.049010507 |
Sensitive |
| ENSG00000273160.1 |
PF-4708671 |
Brain lower grade glioma |
0.040559428 |
Sensitive |
| ENSG00000174171.4 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.004905533 |
Sensitive |
| ENSG00000223714.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.042272182 |
Sensitive |
| ENSG00000226332.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.035789362 |
Sensitive |
| ENSG00000226853.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.031235179 |
Sensitive |
| ENSG00000233081.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.016705931 |
Sensitive |
| ENSG00000233483.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.013556404 |
Sensitive |
| ENSG00000237819.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.01681339 |
Sensitive |
| ENSG00000238120.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.025839585 |
Sensitive |
| ENSG00000241933.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.018967192 |
Sensitive |
| ENSG00000245248.3 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.045463654 |
Sensitive |
| ENSG00000250057.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.002120091 |
Sensitive |
| ENSG00000253716.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.044212712 |
Sensitive |
| ENSG00000254468.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.023787566 |
Sensitive |
| ENSG00000255145.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.007905049 |
Sensitive |
| ENSG00000257556.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.012832907 |
Sensitive |
| ENSG00000261373.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.010767981 |
Sensitive |
| ENSG00000262837.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.001596087 |
Sensitive |
| ENSG00000265185.2 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.012599665 |
Sensitive |
| ENSG00000267475.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.035219252 |
Sensitive |
| ENSG00000267730.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.042274026 |
Sensitive |
| ENSG00000268205.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.048863342 |
Sensitive |
| ENSG00000269979.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.001761652 |
Sensitive |
| ENSG00000272003.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.001392686 |
Sensitive |
| ENSG00000272068.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.044358422 |
Sensitive |
| ENSG00000272092.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.024156274 |
Sensitive |
| ENSG00000272192.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.038105392 |
Sensitive |
| ENSG00000273355.1 |
PF-4708671 |
Liver hepatocellular carcinoma |
0.038598236 |
Sensitive |
| ENSG00000223751.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.032364151 |
Sensitive |
| ENSG00000225292.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.03673363 |
Sensitive |
| ENSG00000225489.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.043001177 |
Sensitive |
| ENSG00000226113.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.031075742 |
Sensitive |
| ENSG00000226179.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041705153 |
Sensitive |
| ENSG00000227544.4 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028275584 |
Sensitive |
| ENSG00000229425.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.040883171 |
Sensitive |
| ENSG00000230569.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.040009805 |
Sensitive |
| ENSG00000231703.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.032762307 |
Sensitive |
| ENSG00000231817.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044895223 |
Sensitive |
| ENSG00000231830.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029564731 |
Sensitive |
| ENSG00000231992.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.020037216 |
Sensitive |
| ENSG00000232352.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.018565794 |
Sensitive |
| ENSG00000232655.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.04294023 |
Sensitive |
| ENSG00000233223.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.021683101 |
Sensitive |
| ENSG00000234693.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.017145156 |
Sensitive |
| ENSG00000236017.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022327916 |
Sensitive |
| ENSG00000236536.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.048637365 |
Sensitive |
| ENSG00000236757.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.006644985 |
Sensitive |
| ENSG00000236983.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.037599895 |
Sensitive |
| ENSG00000237208.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.049485856 |
Sensitive |
| ENSG00000237587.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.037810479 |
Sensitive |
| ENSG00000240990.5 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044663586 |
Sensitive |
| ENSG00000241125.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044352505 |
Sensitive |
| ENSG00000242593.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045226673 |
Sensitive |
| ENSG00000244649.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.042614843 |
Sensitive |
| ENSG00000245522.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.040699725 |
Sensitive |
| ENSG00000248479.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.007828916 |
Sensitive |
| ENSG00000248790.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044860289 |
Sensitive |
| ENSG00000249395.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.046461859 |
Sensitive |
| ENSG00000250286.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.018502001 |
Sensitive |
| ENSG00000251151.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.030118169 |
Sensitive |
| ENSG00000253404.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045144679 |
Sensitive |
| ENSG00000253508.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.043420446 |
Sensitive |
| ENSG00000253567.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.007272082 |
Sensitive |
| ENSG00000253701.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.02422452 |
Sensitive |
| ENSG00000254238.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.022539257 |
Sensitive |
| ENSG00000254290.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.042783881 |
Sensitive |
| ENSG00000255050.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.038582133 |
Sensitive |
| ENSG00000258815.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.049649193 |
Sensitive |
| ENSG00000259327.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044810126 |
Sensitive |
| ENSG00000259422.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.00722668 |
Sensitive |
| ENSG00000259589.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.025022808 |
Sensitive |
| ENSG00000259723.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.035513635 |
Sensitive |
| ENSG00000259831.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.041637925 |
Sensitive |
| ENSG00000260532.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.040168156 |
Sensitive |
| ENSG00000260650.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.026360817 |
Sensitive |
| ENSG00000260807.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.044645206 |
Sensitive |
| ENSG00000262468.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.036121712 |
Sensitive |
| ENSG00000262745.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.031408185 |
Sensitive |
| ENSG00000262877.3 |
PF-4708671 |
Lung squamous cell carcinoma |
0.045019463 |
Sensitive |
| ENSG00000263011.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.049866038 |
Sensitive |
| ENSG00000265008.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.016740647 |
Sensitive |
| ENSG00000265717.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.047507041 |
Sensitive |
| ENSG00000267130.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.025924354 |
Sensitive |
| ENSG00000267588.2 |
PF-4708671 |
Lung squamous cell carcinoma |
0.028551314 |
Sensitive |
| ENSG00000272783.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.035268677 |
Sensitive |
| ENSG00000273365.1 |
PF-4708671 |
Lung squamous cell carcinoma |
0.029795735 |
Sensitive |
| ENSG00000223734.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041616565 |
Sensitive |
| ENSG00000223813.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023330232 |
Sensitive |
| ENSG00000226380.3 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.03078534 |
Sensitive |
| ENSG00000226471.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019241897 |
Sensitive |
| ENSG00000226950.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020413421 |
Sensitive |
| ENSG00000227803.2 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008621248 |
Sensitive |
| ENSG00000229951.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009314511 |
Sensitive |
| ENSG00000230990.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02402437 |
Sensitive |
| ENSG00000231156.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032186122 |
Sensitive |
| ENSG00000231908.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001598053 |
Sensitive |
| ENSG00000232082.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003738073 |
Sensitive |
| ENSG00000236842.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049573253 |
Sensitive |
| ENSG00000257830.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022612279 |
Sensitive |
| ENSG00000258099.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029429169 |
Sensitive |
| ENSG00000258920.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025190685 |
Sensitive |
| ENSG00000259342.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049389256 |
Sensitive |
| ENSG00000261373.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037357069 |
Sensitive |
| ENSG00000261438.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006801708 |
Sensitive |
| ENSG00000272627.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015691483 |
Sensitive |
| ENSG00000273145.1 |
PF-4708671 |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046224395 |
Sensitive |
| ENSG00000203496.4 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.043623093 |
Sensitive |
| ENSG00000214803.3 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.011432621 |
Sensitive |
| ENSG00000215246.4 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.020180243 |
Sensitive |
| ENSG00000223714.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.013991371 |
Sensitive |
| ENSG00000226291.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.009443694 |
Sensitive |
| ENSG00000226852.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.011723881 |
Sensitive |
| ENSG00000230186.3 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.026418363 |
Sensitive |
| ENSG00000231512.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.045220164 |
Sensitive |
| ENSG00000231628.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.026886665 |
Sensitive |
| ENSG00000231651.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.038206258 |
Sensitive |
| ENSG00000233056.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.027003827 |
Sensitive |
| ENSG00000233427.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.026568021 |
Sensitive |
| ENSG00000234753.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.010654818 |
Sensitive |
| ENSG00000249328.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.048710516 |
Sensitive |
| ENSG00000249464.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.028066688 |
Sensitive |
| ENSG00000254538.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.007112569 |
Sensitive |
| ENSG00000261433.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.042334126 |
Sensitive |
| ENSG00000262172.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.033888423 |
Sensitive |
| ENSG00000262319.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.024823488 |
Sensitive |
| ENSG00000264196.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.001004905 |
Sensitive |
| ENSG00000264647.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.0009933 |
Sensitive |
| ENSG00000265142.2 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.021092482 |
Sensitive |
| ENSG00000266664.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.003653039 |
Sensitive |
| ENSG00000267480.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.034545419 |
Sensitive |
| ENSG00000268375.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.013328755 |
Sensitive |
| ENSG00000269483.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.033032481 |
Sensitive |
| ENSG00000270028.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.025220559 |
Sensitive |
| ENSG00000272219.1 |
PF-4708671 |
Pancreatic adenocarcinoma |
0.034205282 |
Sensitive |
| ENSG00000175701.6 |
PF-4708671 |
Sarcoma |
0.039251799 |
Sensitive |
| ENSG00000185904.7 |
PF-4708671 |
Sarcoma |
0.00460266 |
Sensitive |
| ENSG00000204792.2 |
PF-4708671 |
Sarcoma |
0.0000737 |
Sensitive |
| ENSG00000225521.1 |
PF-4708671 |
Sarcoma |
0.048738036 |
Sensitive |
| ENSG00000226251.1 |
PF-4708671 |
Sarcoma |
0.032519201 |
Sensitive |
| ENSG00000227477.1 |
PF-4708671 |
Sarcoma |
0.042726986 |
Sensitive |
| ENSG00000227740.1 |
PF-4708671 |
Sarcoma |
0.032142633 |
Sensitive |
| ENSG00000228106.1 |
PF-4708671 |
Sarcoma |
0.013441453 |
Sensitive |
| ENSG00000228363.2 |
PF-4708671 |
Sarcoma |
0.012511593 |
Sensitive |
| ENSG00000229154.1 |
PF-4708671 |
Sarcoma |
0.023011469 |
Sensitive |
| ENSG00000230641.1 |
PF-4708671 |
Sarcoma |
0.014518577 |
Sensitive |
| ENSG00000230812.1 |
PF-4708671 |
Sarcoma |
0.01943417 |
Sensitive |
| ENSG00000231131.2 |
PF-4708671 |
Sarcoma |
0.028954144 |
Sensitive |
| ENSG00000231242.1 |
PF-4708671 |
Sarcoma |
0.043983479 |
Sensitive |
| ENSG00000231628.1 |
PF-4708671 |
Sarcoma |
0.017987409 |
Sensitive |
| ENSG00000232725.1 |
PF-4708671 |
Sarcoma |
0.011687214 |
Sensitive |
| ENSG00000232807.2 |
PF-4708671 |
Sarcoma |
0.025259962 |
Sensitive |
| ENSG00000233069.1 |
PF-4708671 |
Sarcoma |
0.017847612 |
Sensitive |
| ENSG00000233547.1 |
PF-4708671 |
Sarcoma |
0.006835407 |
Sensitive |
| ENSG00000235246.1 |
PF-4708671 |
Sarcoma |
0.016360896 |
Sensitive |
| ENSG00000237250.3 |
PF-4708671 |
Sarcoma |
0.036028162 |
Sensitive |
| ENSG00000238273.3 |
PF-4708671 |
Sarcoma |
0.014536662 |
Sensitive |
| ENSG00000242578.1 |
PF-4708671 |
Sarcoma |
0.019706331 |
Sensitive |
| ENSG00000245275.3 |
PF-4708671 |
Sarcoma |
0.002821646 |
Sensitive |
| ENSG00000245281.2 |
PF-4708671 |
Sarcoma |
0.027722463 |
Sensitive |
| ENSG00000246228.2 |
PF-4708671 |
Sarcoma |
0.027006654 |
Sensitive |
| ENSG00000247934.3 |
PF-4708671 |
Sarcoma |
0.047073988 |
Sensitive |
| ENSG00000248150.1 |
PF-4708671 |
Sarcoma |
0.03172213 |
Sensitive |
| ENSG00000249035.2 |
PF-4708671 |
Sarcoma |
0.005773472 |
Sensitive |
| ENSG00000249207.1 |
PF-4708671 |
Sarcoma |
0.041846897 |
Sensitive |
| ENSG00000249746.1 |
PF-4708671 |
Sarcoma |
0.035124843 |
Sensitive |
| ENSG00000250075.1 |
PF-4708671 |
Sarcoma |
0.014777876 |
Sensitive |
| ENSG00000250131.1 |
PF-4708671 |
Sarcoma |
0.031532703 |
Sensitive |
| ENSG00000250551.1 |
PF-4708671 |
Sarcoma |
0.048275908 |
Sensitive |
| ENSG00000254057.1 |
PF-4708671 |
Sarcoma |
0.038172078 |
Sensitive |
| ENSG00000255197.1 |
PF-4708671 |
Sarcoma |
0.033371287 |
Sensitive |
| ENSG00000258454.1 |
PF-4708671 |
Sarcoma |
0.007029657 |
Sensitive |
| ENSG00000259548.1 |
PF-4708671 |
Sarcoma |
0.034293782 |
Sensitive |
| ENSG00000259876.1 |
PF-4708671 |
Sarcoma |
0.029586321 |
Sensitive |
| ENSG00000260145.1 |
PF-4708671 |
Sarcoma |
0.004119437 |
Sensitive |
| ENSG00000260162.2 |
PF-4708671 |
Sarcoma |
0.006155948 |
Sensitive |
| ENSG00000260517.1 |
PF-4708671 |
Sarcoma |
0.043542187 |
Sensitive |
| ENSG00000261327.3 |
PF-4708671 |
Sarcoma |
0.006921553 |
Sensitive |
| ENSG00000261534.1 |
PF-4708671 |
Sarcoma |
0.014718185 |
Sensitive |
| ENSG00000262313.1 |
PF-4708671 |
Sarcoma |
0.031743342 |
Sensitive |
| ENSG00000264269.1 |
PF-4708671 |
Sarcoma |
0.038458979 |
Sensitive |
| ENSG00000264448.2 |
PF-4708671 |
Sarcoma |
0.015800685 |
Sensitive |
| ENSG00000266411.1 |
PF-4708671 |
Sarcoma |
0.049908882 |
Sensitive |
| ENSG00000266541.1 |
PF-4708671 |
Sarcoma |
0.028515291 |
Sensitive |
| ENSG00000266744.1 |
PF-4708671 |
Sarcoma |
0.041505455 |
Sensitive |
| ENSG00000267193.1 |
PF-4708671 |
Sarcoma |
0.045932091 |
Sensitive |
| ENSG00000267380.1 |
PF-4708671 |
Sarcoma |
0.014335468 |
Sensitive |
| ENSG00000267397.1 |
PF-4708671 |
Sarcoma |
0.017278764 |
Sensitive |
| ENSG00000267662.1 |
PF-4708671 |
Sarcoma |
0.031199825 |
Sensitive |
| ENSG00000267919.1 |
PF-4708671 |
Sarcoma |
0.025340929 |
Sensitive |
| ENSG00000269019.1 |
PF-4708671 |
Sarcoma |
0.002598125 |
Sensitive |
| ENSG00000271185.1 |
PF-4708671 |
Sarcoma |
0.034293524 |
Sensitive |
| ENSG00000271734.1 |
PF-4708671 |
Sarcoma |
0.004156294 |
Sensitive |
| ENSG00000272029.1 |
PF-4708671 |
Sarcoma |
0.028971663 |
Sensitive |
| ENSG00000272102.1 |
PF-4708671 |
Sarcoma |
0.04571642 |
Sensitive |
| ENSG00000272146.1 |
PF-4708671 |
Sarcoma |
0.014501957 |
Sensitive |
| ENSG00000273065.1 |
PF-4708671 |
Sarcoma |
0.035654685 |
Sensitive |
| ENSG00000204054.7 |
PF-4708671 |
Skin cutaneous melanoma |
0.012181655 |
Sensitive |
| ENSG00000204055.4 |
PF-4708671 |
Skin cutaneous melanoma |
0.011973314 |
Sensitive |
| ENSG00000215304.3 |
PF-4708671 |
Skin cutaneous melanoma |
0.037077362 |
Sensitive |
| ENSG00000223734.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.00200628 |
Sensitive |
| ENSG00000225442.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.032135681 |
Sensitive |
| ENSG00000226007.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.021006205 |
Sensitive |
| ENSG00000228323.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.00017286 |
Sensitive |
| ENSG00000228478.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.036407754 |
Sensitive |
| ENSG00000229154.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.023465149 |
Sensitive |
| ENSG00000229401.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.041480602 |
Sensitive |
| ENSG00000230082.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.010767255 |
Sensitive |
| ENSG00000231273.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.034602455 |
Sensitive |
| ENSG00000232485.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.042881446 |
Sensitive |
| ENSG00000233825.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.045670779 |
Sensitive |
| ENSG00000234233.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.004696383 |
Sensitive |
| ENSG00000235488.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.045862599 |
Sensitive |
| ENSG00000237073.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.037984557 |
Sensitive |
| ENSG00000238142.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.002776171 |
Sensitive |
| ENSG00000241520.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.024511247 |
Sensitive |
| ENSG00000245468.3 |
PF-4708671 |
Skin cutaneous melanoma |
0.03856612 |
Sensitive |
| ENSG00000245556.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.012589394 |
Sensitive |
| ENSG00000249859.3 |
PF-4708671 |
Skin cutaneous melanoma |
0.030831102 |
Sensitive |
| ENSG00000251175.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.046210721 |
Sensitive |
| ENSG00000251574.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.038084865 |
Sensitive |
| ENSG00000259687.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.022168529 |
Sensitive |
| ENSG00000259773.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.01587108 |
Sensitive |
| ENSG00000259884.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.0000632 |
Sensitive |
| ENSG00000260086.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.026067417 |
Sensitive |
| ENSG00000261267.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.013238879 |
Sensitive |
| ENSG00000261533.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.048073063 |
Sensitive |
| ENSG00000261837.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.030629294 |
Sensitive |
| ENSG00000264125.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.039706323 |
Sensitive |
| ENSG00000266900.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.018926923 |
Sensitive |
| ENSG00000267221.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.042992385 |
Sensitive |
| ENSG00000267519.2 |
PF-4708671 |
Skin cutaneous melanoma |
0.007525954 |
Sensitive |
| ENSG00000268401.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.015469681 |
Sensitive |
| ENSG00000269990.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.029735953 |
Sensitive |
| ENSG00000270020.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.041650106 |
Sensitive |
| ENSG00000270755.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.024408543 |
Sensitive |
| ENSG00000272023.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.024786544 |
Sensitive |
| ENSG00000272449.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.004862536 |
Sensitive |
| ENSG00000273456.1 |
PF-4708671 |
Skin cutaneous melanoma |
0.03666998 |
Sensitive |
| ENSG00000229941.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.047383362 |
Sensitive |
| ENSG00000254791.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.021087266 |
Sensitive |
| ENSG00000259135.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.009547744 |
Sensitive |
| ENSG00000268686.1 |
PF-4708671 |
Stomach adenocarcinoma |
0.007425762 |
Sensitive |
